Yazdan Yazdanpanah
#36,634
Most Influential Person Now
French-Iranian infectiologist
Yazdan Yazdanpanah's AcademicInfluence.com Rankings
Yazdan Yazdanpanahphilosophy Degrees
Philosophy
#5272
World Rank
#8030
Historical Rank
Logic
#3576
World Rank
#4763
Historical Rank
Download Badge
Philosophy
Why Is Yazdan Yazdanpanah Influential?
(Suggest an Edit or Addition)According to Wikipedia, Yazdan Yazdanpanah is an Iranian born infectiologist who is head of the Infectious Disease department at Bichat–Claude Bernard Hospital. He was Professor of Medicine at Paris Diderot University. He became an MD from the Lille School of Medicine in 1996, obtained a Master of Science in epidemiology from the Harvard School of Public Health in 2000, and completed a PhD in public health from the Bordeaux School of Public Health in 2002.
Yazdan Yazdanpanah's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Severe Acute Respiratory Syndrome Coronavirus 2−Specific Antibody Responses in Coronavirus Disease Patients (2020) (1198)
- Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. (2009) (950)
- Clinical and virological data of the first cases of COVID-19 in Europe: a case series (2020) (946)
- Preparedness and vulnerability of African countries against importations of COVID-19: a modelling study (2020) (928)
- Type 1 interferons as a potential treatment against COVID-19 (2020) (439)
- Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea (2016) (437)
- European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. (2009) (410)
- Short statement of the first European Consensus Conference on the treatment of chronic hepatitis B and C in HIV co-infected patients. (2005) (410)
- Evidence of Sexual Transmission of Zika Virus. (2016) (356)
- Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial (2017) (339)
- Culture of percutaneous bone biopsy specimens for diagnosis of diabetic foot osteomyelitis: concordance with ulcer swab cultures. (2006) (281)
- Cost-effectiveness of HIV treatment in resource-poor settings--the case of Côte d'Ivoire. (2006) (272)
- Severe SARS-CoV-2 infections: practical considerations and management strategy for intensivists (2020) (259)
- Review of human immunodeficiency virus type 1-related opportunistic infections in sub-Saharan Africa. (2003) (249)
- High rate of virologic suppression with raltegravir plus etravirine and darunavir/ritonavir among treatment-experienced patients infected with multidrug-resistant HIV: results of the ANRS 139 TRIO trial. (2009) (237)
- Symptomatic hyperlactataemia: an emerging complication of antiretroviral therapy (2000) (219)
- Durable Efficacy and Safety of Raltegravir Versus Efavirenz When Combined With Tenofovir/Emtricitabine in Treatment-Naive HIV-1–Infected Patients: Final 5-Year Results From STARTMRK (2013) (219)
- SARS-CoV-2 specific antibody responses in COVID-19 patients (2020) (214)
- Outcome of Diabetic Foot Osteomyelitis Treated Nonsurgically (2008) (207)
- A comparison of four serological assays for detecting anti–SARS-CoV-2 antibodies in human serum samples from different populations (2020) (205)
- Outcome and Predictors of Treatment Failure in Total Hip/Knee Prosthetic Joint Infections Due to Staphylococcus aureus (2011) (204)
- Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial (2021) (195)
- [Risk factors for hepatitis C virus transmission to Health Care Workers after occupational exposure: a European case-control study]. (2005) (194)
- Characterization and Treatment of SARS-CoV-2 in Nasal and Bronchial Human Airway Epithelia (2020) (191)
- WHO Rapid Advice Guidelines for pharmacological management of sporadic human infection with avian influenza A (H5N1) virus (2006) (186)
- Opportunistic infections in patients with inflammatory bowel disease: prevention and diagnosis (2007) (185)
- Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial (2021) (168)
- Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial (2021) (168)
- The French Connection: The First Large Population-Based Contact Survey in France Relevant for the Spread of Infectious Diseases (2015) (162)
- Pharmacokinetics, safety and efficacy of a full dose sofosbuvir-based regimen given daily in hemodialysis patients with chronic hepatitis C. (2016) (159)
- Collecting and evaluating convalescent plasma for COVID‐19 treatment: why and how? (2020) (144)
- Impact of Drug Stock-Outs on Death and Retention to Care among HIV-Infected Patients on Combination Antiretroviral Therapy in Abidjan, Côte d'Ivoire (2010) (136)
- Transparent Development of the WHO Rapid Advice Guidelines (2007) (131)
- The cost-effectiveness of rotavirus vaccination: Comparative analyses for five European countries and transferability in Europe. (2009) (122)
- Modeling SARS-CoV-2 viral kinetics and association with mortality in hospitalized patients from the French COVID cohort (2021) (121)
- Routine HIV Screening in France: Clinical Impact and Cost-Effectiveness (2010) (121)
- The Chikungunya Epidemic on La Réunion Island in 2005–2006: A Cost-of-Illness Study (2011) (119)
- Blood-borne viruses in health care workers: prevention and management. (2011) (112)
- Needle puncture and transcutaneous bone biopsy cultures are inconsistent in patients with diabetes and suspected osteomyelitis of the foot. (2009) (107)
- Outcome of SARS-CoV-2 infection is linked to MAIT cell activation and cytotoxicity (2021) (107)
- Long-term outcome and safety of prolonged bedaquiline treatment for multidrug-resistant tuberculosis (2017) (103)
- Viral-bacterial coinfection affects the presentation and alters the prognosis of severe community-acquired pneumonia (2016) (103)
- Characteristics and prognosis in patients with prosthetic vascular graft infection: a prospective observational cohort study. (2012) (98)
- Rifampicin-ofloxacin oral regimen for the treatment of mild to moderate diabetic foot osteomyelitis. (2001) (98)
- Risk factors of chronic kidney disease in HIV-infected patients. (2011) (90)
- Effectiveness and tolerability of prolonged linezolid treatment for chronic osteomyelitis: a retrospective study. (2006) (89)
- Clinical impact and cost-effectiveness of co-trimoxazole prophylaxis in patients with HIV/AIDS in Côte d’Ivoire: a trial-based analysis (2005) (89)
- Evaluation of the QIAstat-Dx Respiratory SARS-CoV-2 Panel, the First Rapid Multiplex PCR Commercial Assay for SARS-CoV-2 Detection (2020) (88)
- Average adherence to boosted protease inhibitor therapy, rather than the pattern of missed doses, as a predictor of HIV RNA replication. (2010) (88)
- Missed opportunities for HIV testing in newly-HIV-diagnosed patients, a cross sectional study (2013) (87)
- Mycobacterium xenopi pulmonary infections: a multicentric retrospective study of 136 cases in north-east France (2008) (87)
- Newer drugs and earlier treatment: impact on lifetime cost of care for HIV-infected adults (2012) (86)
- Factors associated with virological failure in HIV-1-infected patients receiving darunavir/ritonavir monotherapy. (2011) (85)
- Scaling up antiretroviral therapy in South Africa: the impact of speed on survival. (2008) (81)
- Risk factors for anaemia in patients on prolonged linezolid therapy for chronic osteomyelitis: a case-control study. (2004) (81)
- Hepatitis C treatment as prevention of viral transmission and liver‐related morbidity in persons who inject drugs (2016) (80)
- SARS-CoV-2 serological analysis of COVID-19 hospitalized patients, pauci-symptomatic individuals and blood donors. (2020) (78)
- Long term SARS-CoV-2 infectiousness among three immunocompromised patients: from prolonged viral shedding to SARS-CoV-2 superinfection (2021) (78)
- Long-Lasting Persistence of Zika Virus in Semen. (2016) (78)
- Bictegravir combined with emtricitabine and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection: week 96 results from a randomised, double-blind, multicentre, phase 3, non-inferiority trial. (2019) (77)
- Review of trials currently testing treatment and prevention of COVID-19 (2020) (77)
- Cost and cost-effectiveness of childhood vaccination against rotavirus in France. (2007) (76)
- Challenges and issues about organizing a hospital to respond to the COVID-19 outbreak: experience from a French reference centre (2020) (76)
- Clinical efficacy of antiretroviral combination therapy based on protease inhibitors or non-nucleoside analogue reverse transcriptase inhibitors: indirect comparison of controlled trials (2004) (75)
- Efficacy and tolerance of rifampicin-linezolid compared with rifampicin-cotrimoxazole combinations in prolonged oral therapy for bone and joint infections. (2009) (74)
- H1N1 vaccines in a large observational cohort of patients with inflammatory bowel disease treated with immunomodulators and biological therapy (2011) (74)
- Clinical characteristics of ambulatory and hospitalized patients with monkeypox virus infection: an observational cohort study (2022) (73)
- Prevention of Ebola virus disease through vaccination: where we are in 2018 (2018) (72)
- Impact of Human Immunodeficiency Virus Type 1 Subtype on First-Line Antiretroviral Therapy Effectiveness (2005) (72)
- Hepatitis C: The beginning of the end—key elements for successful European and national strategies to eliminate HCV in Europe (2018) (70)
- A Single HIV-1 Cluster and a Skewed Immune Homeostasis Drive the Early Spread of HIV among Resting CD4+ Cell Subsets within One Month Post-Infection (2013) (68)
- Incidence of primary opportunistic infections in two human immunodeficiency virus-infected French clinical cohorts. (2001) (67)
- Increasing HIV-1 non-B subtype primary infections in patients in France and effect of HIV subtypes on virological and immunological responses to combined antiretroviral therapy. (2013) (67)
- Auditing HIV Testing Rates across Europe: Results from the HIDES 2 Study (2015) (66)
- Factors associated with delay to acyclovir administration in 184 patients with herpes simplex virus encephalitis. (2009) (66)
- Factors associated with presentation to care with advanced HIV disease in Brussels and Northern France: 1997-2007 (2011) (66)
- Should we await IFN-free regimens to treat HCV genotype 1 treatment-naive patients? A cost-effectiveness analysis (ANRS 95141). (2014) (64)
- Characteristics of and outcomes in HIV-infected patients who return to care after loss to follow-up (2009) (64)
- Rapid emergence of Mycobacterium tuberculosis bedaquiline resistance: lessons to avoid repeating past errors (2017) (64)
- Dolutegravir and lamivudine maintenance therapy in HIV-1 virologically suppressed patients: results of the ANRS 167 trial (LAMIDOL) (2018) (63)
- Switch from enfuvirtide to raltegravir in virologically suppressed multidrug-resistant HIV-1-infected patients: a randomized open-label trial. (2009) (62)
- Risk factors for early catheter‐related infections in cancer patients (2007) (62)
- Assessment of the Middle East respiratory syndrome coronavirus (MERS-CoV) epidemic in the Middle East and risk of international spread using a novel maximum likelihood analysis approach. (2014) (61)
- Treatment of Ebola virus disease (2014) (61)
- Morbidité et coût des infections à rotavirus en France (2005) (60)
- The Independent Effect of Highly Active Antiretroviral Therapy on Severe Opportunistic Disease Incidence and Mortality in HIV-Infected Adults in Côte D'Ivoire (2007) (59)
- The negative impact of HBV/HCV coinfection on cirrhosis and its consequences (2017) (59)
- ANRS–COM'TEST: description of a community-based HIV testing intervention in non-medical settings for men who have sex with men (2012) (59)
- Additional direct medical costs associated with nosocomial infections after head and neck cancer surgery: a hospital-perspective analysis. (2008) (59)
- Assessing the cost-effectiveness of hepatitis C screening strategies in France. (2018) (58)
- Bone loss in patients with HIV infection. (2009) (57)
- Impact of viral eradication on mortality related to hepatitis C: a modeling approach in France. (2008) (57)
- Laboratory Monitoring to Guide Switching Antiretroviral Therapy in Resource-Limited Settings: Clinical Benefits and Cost-Effectiveness (2010) (56)
- Routine HIV Screening in Portugal: Clinical Impact and Cost-Effectiveness (2012) (56)
- Hepatocellular carcinoma screening in patients with compensated hepatitis C virus (HCV)‐related cirrhosis aware of their HCV status improves survival: A modeling approach (2014) (55)
- Tolerability of prolonged linezolid therapy in bone and joint infection: protective effect of rifampicin on the occurrence of anaemia? (2010) (54)
- Lifetime Cost of HIV Care in France during the Era of Highly Active Antiretroviral Therapy (2001) (53)
- Organometric investigations of the spleen and liver by ultrasound in Schistosoma mansoni endemic and nonendemic villages in Senegal. (1997) (53)
- Costs associated with combination antiretroviral therapy in HIV-infected patients. (2004) (53)
- Incidence of and risk factors for severe liver toxicity in HIV-infected patients on anti-tuberculosis treatment. (2007) (53)
- An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19 (2021) (52)
- Clinical characteristics and outcome of respiratory syncytial virus infection among adults hospitalized with influenza-like illness in France (2016) (52)
- Prevalence of respiratory viruses among adults, by season, age, respiratory tract region and type of medical unit in Paris, France, from 2011 to 2016 (2017) (50)
- Impact of surgery on quality of life in Crohn's disease. (1997) (50)
- Impact of respiratory viruses in hospital-acquired pneumonia in the intensive care unit: A single-center retrospective study (2017) (50)
- COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study (2021) (49)
- Introduction of SARS in France, March–April, 2003 (2004) (49)
- Improved aero-anaerobe recovery from infected prosthetic joint samples taken from 72 patients and collected intraoperatively in Rosenow's broth (2006) (49)
- The European (ECCO) Consensus on infection in IBD: what does it change for the clinician? (2009) (48)
- Treatment of bone and joint infections caused by Gram-negative bacilli with a cefepime-fluoroquinolone combination. (2006) (47)
- Detection of SARS-CoV-2 N-antigen in blood during acute COVID-19 provides a sensitive new marker and new testing alternatives (2020) (47)
- Detection of SARS-CoV-2 N-antigen in blood during acute COVID-19 provides a sensitive new marker and new testing alternatives (2020) (47)
- An update to "The cost-effectiveness of rotavirus vaccination: comparative analyses for five European countries and transferability in Europe". (2010) (46)
- A brief review of antiviral drugs evaluated in registered clinical trials for COVID-19 (2020) (46)
- Hand Hygiene, Cohorting, or Antibiotic Restriction to Control Outbreaks of Multidrug-Resistant Enterobacteriaceae (2015) (46)
- Cost-Effectiveness of Primary Prophylaxis of AIDS Associated Cryptococcosis in Cambodia (2010) (44)
- Cost-effectiveness of QuantiFERON-TB test vs. tuberculin skin test in the diagnosis of latent tuberculosis infection. (2010) (44)
- Contribution of alcohol use disorders on the burden of chronic hepatitis C in France, 2008-2013: A nationwide retrospective cohort study. (2017) (43)
- Bedaquiline plus delamanid for XDR tuberculosis. (2016) (43)
- Human plague: An old scourge that needs new answers (2020) (42)
- Arterial Thrombotic Events in Adult Inpatients With COVID-19 (2020) (42)
- Earlier Testing for HIV – How do we Prevent Late Presentation? (2010) (42)
- Cefazolin versus anti-staphylococcal penicillins for treatment of methicillin-susceptible Staphylococcus aureus bacteraemia: a narrative review. (2017) (41)
- Characteristics trends, mortality and morbidity in persons newly diagnosed HIV positive during the last decade: the profile of new HIV diagnosed people. (2008) (41)
- Impact of mass testing during an epidemic rebound of SARS-CoV-2: a modelling study using the example of France (2020) (41)
- CD177, a specific marker of neutrophil activation, is associated with coronavirus disease 2019 severity and death (2021) (41)
- Long-Term Efficacy and Safety of Raltegravir, Etravirine, and Darunavir/Ritonavir in Treatment-Experienced Patients: Week 96 Results From the ANRS 139 TRIO Trial (2012) (40)
- Factors determining length of the postoperative hospital stay after major head and neck cancer surgery. (2008) (40)
- Incidence rate and risk factors for loss to follow‐up in a French clinical cohort of HIV‐infected patients from January 1985 to January 1998 (2006) (39)
- Discontinuing β-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial (2021) (37)
- Prevention of surgical site infection after breast cancer surgery by targeted prophylaxis antibiotic in patients at high risk of surgical site infection (2007) (37)
- Silent Cerebral Small-Vessel Disease Is Twice as Prevalent in Middle-Aged Individuals With Well-Controlled, Combination Antiretroviral Therapy–Treated Human Immunodeficiency Virus (HIV) Than in HIV-Uninfected Individuals (2018) (36)
- Evolution of outcomes for patients hospitalised during the first 9 months of the SARS-CoV-2 pandemic in France: A retrospective national surveillance data analysis (2021) (36)
- Silent Cerebral Small-Vessel Disease Is Twice as Prevalent in Middle-Aged Individuals With Well-Controlled, Combination Antiretroviral Therapy–Treated Human Immunodeficiency Virus (HIV) Than in HIV-Uninfected Individuals (2018) (36)
- Endocarditis due to gram-negative bacilli at a French teaching hospital over a 6-year period: clinical characteristics and outcome (2015) (36)
- Persistence and adherence to single-tablet regimens in HIV treatment: a cohort study from the French National Healthcare Insurance Database. (2015) (36)
- 2014 French guidelines for hepatitis B and C screening: a combined targeted and mass testing strategy of chronic viruses namely HBV, HCV and HIV (2016) (35)
- Effectiveness and cost-effectiveness of immediate versus delayed treatment of hepatitis C virus-infected patients in a country with limited resources: the case of Egypt. (2014) (35)
- Ultrasonography in a Senegalese community recently exposed to Schistosoma mansoni infection. (1996) (35)
- First cases of Omicron in France are exhibiting mild symptoms, November 2021–January 2022 (2022) (35)
- Incidence rate and risk factors for loss to follow-up in HIV-infected patients from five French clinical centres in Northern France – January 1997 to December 2006 (2008) (35)
- Research priorities for Long Covid: refined through an international multi-stakeholder forum (2021) (34)
- Integrase strand transfer inhibitors and neuropsychiatric adverse events in a large prospective cohort (2018) (34)
- Switching to Bictegravir, Emtricitabine, and Tenofovir Alafenamide in Virologically Suppressed Adults With Human Immunodeficiency Virus (2020) (34)
- Qualité de vie dans les maladies inflammatoires chroniques de l'intestin. Validation d'un questionnaire et premières données françaises. (1996) (34)
- Hospital-acquired pneumonia: microbiological data and potential adequacy of antimicrobial regimens (2002) (33)
- Risk factors for syphilis infection in men who have sex with men: results of a case–control study in Lille, France (2012) (33)
- French Intensive Care Society, International congress – Réanimation 2016 (2016) (33)
- Linezolid-induced neuropathy. (2004) (33)
- Evaluation of ultrasonographic staging systems for the assessment of Schistosoma mansoni induced hepatic involvement. (1997) (33)
- Report of a European Working Group on Late Presentation with HIV Infection: Recommendations and Regional Variation (2010) (32)
- Quinolones versus macrolides in the treatment of legionellosis: a systematic review and meta-analysis. (2014) (32)
- Efficacy of new antiretroviral drugs in treatment‐experienced HIV‐infected patients: a systematic review and meta‐analysis of recent randomized controlled trials (2011) (32)
- Case report study of the first five COVID-19 patients treated with remdesivir in France (2020) (32)
- Should highly active antiretroviral therapy be prescribed in critically ill HIV-infected patients during the ICU stay? A retrospective cohort study (2012) (32)
- Impact on disease mortality of clinical, biological, and virological characteristics at hospital admission and overtime in COVID‐19 patients (2020) (31)
- Preparedness and vulnerability of African countries against introductions of 2019-nCoV (2020) (30)
- Efficacy and safety of emtricitabine/tenofovir alafenamide (FTC/TAF) vs. emtricitabine/tenofovir disoproxil fumarate (FTC/TDF) as a backbone for treatment of HIV-1 infection in virologically suppressed adults: subgroup analysis by third agent of a randomized, double-blind, active-controlled phase 3 (2017) (30)
- Effectiveness and cost‐effectiveness of interventions targeting harm reduction and chronic hepatitis C cascade of care in people who inject drugs: The case of France (2018) (30)
- Risk of hepatitis C virus transmission to surgeons and nurses from infected patients: model-based estimates in France. (1999) (30)
- Prevention of human immunodeficiency virus-related opportunistic infections in France: a cost-effectiveness analysis. (2003) (30)
- The need for treatment scale-up to impact HCV transmission in people who inject drugs in Montréal, Canada: a modelling study (2017) (30)
- Prevention of surgical site infection after breast cancer surgery by targeted prophylaxis antibiotic in patients at high risk of surgical site infection. (2007) (30)
- Therapeutic Drug Monitoring in HIV Treatment: A Literature Review (2006) (30)
- Safety and efficacy of exposure to bedaquiline−delamanid in multidrug-resistant tuberculosis: a case series from France and Latvia (2018) (29)
- Emergence of E484K Mutation Following Bamlanivimab Monotherapy among High-Risk Patients Infected with the Alpha Variant of SARS-CoV-2 (2021) (29)
- Complications following intravesical bacillus Calmette-Guerin treatment for bladder cancer: a case series of 22 patients (2015) (29)
- Assessment of the MERS-CoV epidemic situation in the Middle East region (2013) (28)
- Raltegravir 1200 mg once daily versus raltegravir 400 mg twice daily, with tenofovir disoproxil fumarate and emtricitabine, for previously untreated HIV-1 infection: a randomised, double-blind, parallel-group, phase 3, non-inferiority trial. (2017) (28)
- HIV drug resistance surveillance for prioritizing treatment in resource-limited settings (2007) (28)
- Prosthetic Valve Candida spp. Endocarditis: New Insights Into Long-term Prognosis—The ESCAPE Study (2018) (28)
- Nebulised interferon beta-1a for patients with COVID-19 (2020) (28)
- CD4+ T-cell percentage is an independent predictor of clinical progression in AIDS-free antiretroviral-naive patients with CD4+ T-cell counts >200 cells/mm3 (2008) (28)
- Cancer-associated hypercalcemia treated with intravenous diphosphonates: a survival and prognostic factor analysis (2008) (27)
- Immediate vs. delayed treatment in patients with acute hepatitis C based on IL28B polymorphism: a model-based analysis. (2012) (27)
- Vitamin D deficiency in HIV-infected patients: associated with non-nucleoside reverse transcriptase inhibitor or efavirenz use? (2011) (27)
- Dynamic modelling of hepatitis C virus transmission among people who inject drugs: a methodological review (2013) (27)
- How to optimize hepatitis C virus treatment impact on life years saved in resource‐constrained countries (2015) (27)
- Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial (2020) (26)
- Review article: influenza A (H1N1) virus in patients with inflammatory bowel disease (2009) (26)
- Highly frequent HIV-1 minority resistant variants at baseline of the ANRS 139 TRIO trial had a limited impact on virological response. (2015) (26)
- Is Universal HBV Vaccination of Healthcare Workers a Relevant Strategy in Developing Endemic Countries? The Case of a University Hospital in Niger (2012) (26)
- Cost‐effectiveness and budget impact of interferon‐free direct‐acting antiviral‐based regimens for hepatitis C treatment: the French case (2016) (26)
- Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial (2020) (26)
- Outbreak of Pneumocystis jirovecii Infection Among Heart Transplant Recipients: Molecular Investigation and Management of an Interhuman Transmission (2017) (26)
- Costs associated with implementation of a strict policy for controlling spread of highly resistant microorganisms in France (2016) (25)
- Temporal Trends in Suicide Attempts Among Children in the Decade Before and During the COVID-19 Pandemic in Paris, France (2021) (25)
- Timing of Intermittent Seminal HIV-1 RNA Shedding in Patients with Undetectable Plasma Viral Load under Combination Antiretroviral Therapy (2014) (25)
- Baseline CD4 Cell Count and Outcome of Pegylated Interferon Plus Ribavirin Therapy in HIV/Hepatitis C Virus-Coinfected Patients (2008) (25)
- Prevalence of gag mutations associated with in vitro resistance to capsid inhibitor GS-CA1 in HIV-1 antiretroviral-naive patients (2017) (25)
- A monoclonal antibody stands out against omicron subvariants: a call to action for a wider access to bebtelovimab (2022) (24)
- Impact of Herpes simplex virus load and red blood cells in cerebrospinal fluid upon herpes simplex meningo-encephalitis outcome (2012) (24)
- Decreasing humoral response among healthcare workers up to 4 months after two doses of BNT162b2 vaccine (2021) (24)
- Outcome of patients with diabetes with negative percutaneous bone biopsy performed for suspicion of osteomyelitis of the foot (2012) (24)
- Sarilumab in adults hospitalised with moderate-to-severe COVID-19 pneumonia (CORIMUNO-SARI-1): An open-label randomised controlled trial (2021) (24)
- A highly virulent variant of HIV-1 circulating in the Netherlands (2022) (23)
- Plague: Bridging gaps towards better disease control. (2018) (23)
- Corticosteroids in patients hospitalized for COVID-19 pneumonia who require oxygen: observational comparative study using routine care data (2020) (23)
- Introduction of highly resistant bacteria into a hospital via patients repatriated or recently hospitalized in a foreign country. (2014) (23)
- Tolerability of two different combinations of antiretroviral drugs including tenofovir used in occupational and nonoccupational postexposure prophylaxis for HIV. (2010) (23)
- Pharmacokinetics of etravirine, raltegravir and darunavir/ritonavir in treatment experienced patients (2010) (22)
- Improving the evidence for indicator condition guided HIV testing in Europe: Results from the HIDES II Study – 2012 – 2015 (2019) (22)
- Estimates of opportunistic infection incidence or death within specific CD4 strata in HIV-infected patients in Abidjan, Côte d’Ivoire: impact of alternative methods of CD4 count modelling (2007) (22)
- Experiences and perspectives of implementing antimicrobial stewardship in five French hospitals: a qualitative study. (2018) (22)
- Safety of Prolonged High-Dose Levofloxacin Therapy for Bone Infections (2007) (22)
- Retention in care for HIV-infected patients in the eye of the Ebola storm: lessons from Monrovia, Liberia. (2015) (22)
- Mortality due to ventilator-associated pneumonia: impact of medical versus surgical ICU admittance status. (2001) (22)
- Evaluation of HIV testing recommendations in specialty guidelines for the management of HIV indicator conditions (2016) (22)
- Is Total Community Viral Load a Robust Predictive Marker of the Efficacy of the TasP Strategy? (2012) (22)
- Impact of hepatitis C triple therapy availability upon the number of patients to be treated and associated costs in France: a model-based analysis (2011) (21)
- Economic evaluation of ART in resource-limited countries (2010) (21)
- [Morbidity and cost of rotavirus infections in France]. (2005) (21)
- Immediate Versus Deferred Switching From a Boosted Protease Inhibitor–based Regimen to a Dolutegravir-based Regimen in Virologically Suppressed Patients With High Cardiovascular Risk or Age ≥50 Years: Final 96-Week Results of the NEAT022 Study (2018) (21)
- Pneumocystis Cytochrome b Mutants Associated With Atovaquone Prophylaxis Failure as the Cause of Pneumocystis Infection Outbreak Among Heart Transplant Recipients (2018) (21)
- Sternal Wound Infection after Cardiac Surgery: Management and Outcome (2015) (20)
- Is bedaquiline as effective as fluoroquinolones in the treatment of multidrug-resistant tuberculosis? (2016) (20)
- Presence of HIV-1 Nef specific CD4 T cell response is associated with non-progression in HIV-1 infection. (2007) (20)
- Resistance analyses in highly experienced patients failing raltegravir, etravirine and darunavir/ritonavir regimen (2010) (20)
- Drug reaction with eosinophilia and systemic symptoms, or virus reactivation with eosinophilia and systemic symptoms as a manifestation of immune reconstitution inflammatory syndrome in a patient with HIV? (2014) (20)
- Likely effect of the 2014 Ebola epidemic on HIV care in Liberia (2015) (19)
- Costs and cost-effectiveness of different follow-up schedules for detection of occupational hepatitis C virus infection (2008) (19)
- Prevalence of subtype-related polymorphisms associated with in vitro resistance to attachment inhibitor BMS-626529 in HIV-1 'non-B'-infected patients. (2012) (19)
- Risk factors of acute diarrhoea in summer – a nation-wide French case-control study (2000) (19)
- Impact of opportunistic diseases on chronic mortality in HIV-infected adults in Côte d'Ivoire. (2006) (18)
- Universal or targeted approach to prevent the transmission of extended-spectrum beta-lactamase-producing Enterobacteriaceae in intensive care units: a cost-effectiveness analysis (2017) (18)
- Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs (2022) (18)
- French 2010-2011 measles outbreak in adults: report from a Parisian teaching hospital. (2014) (18)
- France's COVID-19 response: balancing conflicting public health traditions (2020) (17)
- Islatravir in combination with doravirine for treatment-naive adults with HIV-1 infection receiving initial treatment with islatravir, doravirine, and lamivudine: a phase 2b, randomised, double-blind, dose-ranging trial. (2021) (17)
- The long‐term benefits of genotypic resistance testing in patients with extensive prior antiretroviral therapy: a model‐based approach (2007) (17)
- Expected response to protease inhibitors of HIV-1 non-B subtype viruses according to resistance algorithms (2008) (17)
- The value of open-source clinical science in pandemic response: lessons from ISARIC (2021) (17)
- Severe liver toxicity in postexposure prophylaxis for HIV infection with a zidovudine, lamivudine and fosamprenavir/ritonavir regimen. (2007) (17)
- Incidence of diabetes in HIV-infected patients treated with first-line integrase strand transfer inhibitors: a French multicentre retrospective study. (2020) (17)
- Budget impact of antiretroviral therapy in a French clinic cohort (2017) (16)
- Predictive Factors of Cytomegalovirus Seropositivity among Pregnant Women in Paris, France (2014) (16)
- OUTCOME OF DIABETIC FOOT OSTEOMYELITIS TREATED NON-SURGICALLY: A RETROSPECTIVE COHORT STUDY (2008) (16)
- Rapid detection of glycopeptide-resistant enterococci: impact on decision-making and costs (2013) (16)
- Characterization of Binding of Raltegravir to Plasma Proteins (2013) (16)
- Screening and vaccination against COVID-19 to minimise school closure: a modelling study (2022) (16)
- Staphylococcus simulans as an authentic pathogenic agent of osteoarticular infections (2011) (15)
- Prophylaxie antipaludenne par plantes mdicinales: hpatite toxique Tinospora crispa (2007) (15)
- Orogenital Transmission of Neisseria meningitidis Causing Acute Urethritis in Men Who Have Sex with Men (2019) (15)
- Intervention Packages to Reduce the Impact of HIV and HCV Infections Among People Who Inject Drugs in Eastern Europe and Central Asia: A Modeling and Cost-effectiveness Study (2018) (15)
- Ethics and hepatitis B cure research (2016) (15)
- Impact of obesity on antiretroviral pharmacokinetics and immuno-virological response in HIV-infected patients: a case–control study (2017) (15)
- HIV therapeutic vaccine enhances non-exhausted CD4+ T cells in a randomised phase 2 trial (2019) (15)
- Targeted vs. systematic early antiviral treatment against A(H1N1)v influenza with neuraminidase inhibitors in patients with influenza-like symptoms: Clinical and economic impact (2009) (15)
- Association between renin–angiotensin–aldosterone system blockers and outcome in coronavirus disease 2019: analysing in-hospital exposure generates a biased seemingly protective effect of treatment (2020) (15)
- Prevalence of HIV-1 drug resistance among patients failing first-line ART in Monrovia, Liberia: a cross-sectional study. (2015) (15)
- Intensification of Antiretroviral Therapy through Addition of Enfuvirtide in Naive HIV-1-Infected Patients with Severe Immunosuppression Does Not Improve Immunological Response: Results of a Randomized Multicenter Trial (ANRS 130 Apollo) (2012) (15)
- 49 LIFETIME COSTS ATTRIBUTABLE TO CHRONIC HEPATITIS C FROM THE FRENCH HEALTHCARE PERSPECTIVE (ANRS N°12188) (2013) (15)
- Influenza A (H1N1)v infection in patients with inflammatory bowel disease: a case series (2011) (14)
- Quality of life in patients with chronic hepatitis C infection: Severe comorbidities and disease perception matter more than liver-disease stage (2019) (14)
- Clinical and immunological effects of a 6 week immunotherapy cycle with murabutide in HIV-1 patients with unsuccessful long-term antiretroviral treatment. (2003) (14)
- Effectiveness of childhood vaccination against rotavirus in sub-Saharan Africa: the case of Nigeria. (2007) (14)
- Zika virus infection: report of the first imported cases in a Paris travel centre (2016) (14)
- Melioidotic osteomyelitis of the femur occurring in a traveler. (2002) (14)
- [Zika virus infection during pregnancy]. (2016) (14)
- Strengthening the global effort on COVID-19 research (2020) (14)
- Manifestations extra-cutanéomuqueuses de la syphilis secondaire (2008) (14)
- The HIV cure research agenda: the role of mathematical modelling and cost-effectiveness analysis (2015) (14)
- Alpha (B.1.1.7) and Delta (B.1.617.2 – AY.40) SARS-CoV-2 variants present strong neutralization decay at M4 post-vaccination and a faster replication rates than D614G (B.1) lineage (2021) (14)
- Comparison of vancomycin and teicoplanin trough serum levels in patients with infected orthopedic devices: new data for old therapies (2011) (13)
- Lumbar punctures: use and diagnostic efficiency in emergency medical departments (2009) (13)
- Outcome of SARS-CoV-2 infection linked to MAIT cell activation and cytotoxicity: evidence for an IL-18 dependent mechanism (2020) (13)
- Randomized Placebo-Controlled Study of the Safety, Tolerability, Antiviral Activity, and Pharmacokinetics of 10-Day Monotherapy With BMS-986001, a Novel HIV NRTI, in Treatment-Experienced HIV-1–Infected Subjects (2013) (13)
- Introduction to Late Presentation for HIV Treatment in Europe (2010) (13)
- REACTing: the French response to infectious disease crises (2016) (13)
- Thymidine analogue mutations in antiretroviral-naive HIV-1 patients on triple therapy including either zidovudine or stavudine. (2003) (13)
- Cost-effectiveness of rabies post-exposure prophylaxis in the context of very low rabies risk: A decision-tree model based on the experience of France. (2015) (13)
- Immunogenicity of BNT162b2 vaccine booster against SARS-CoV-2 Delta and Omicron variants in nursing home residents: A prospective observational study in older adults aged from 68 to 98 years (2022) (13)
- Hyperlactataemia during antiretroviral therapy: incidences, clinical data and treatment. (2003) (13)
- Advancing preparedness for clinical research during infectious disease epidemics (2019) (13)
- Influence of Sex/Gender and Race on Responses to Raltegravir Combined With Tenofovir-Emtricitabine in Treatment-Naive Human Immunodeficiency Virus-1 Infected Patients: Pooled Analyses of the STARTMRK and QDMRK Studies (2017) (13)
- No impact of HIV-1 protease minority resistant variants on the virological response to a first-line PI-based regimen containing darunavir or atazanavir (2018) (12)
- Community acquired pneumonia in the emergency department: an algorithm to facilitate diagnosis and guide chest CT-scan indication. (2020) (12)
- Ebola: Europe-Africa research collaborations. (2015) (12)
- Efficacy, safety and patient‐reported outcomes of ledipasvir/sofosbuvir in NS3/4A protease inhibitor‐experienced individuals with hepatitis C virus genotype 1 and HIV coinfection with and without cirrhosis (ANRS HC31 SOFTRIH study) (2018) (12)
- SARS-COV2 infection in 30 HIV-infected patients followed-up in a French University Hospital (2020) (12)
- Predictive Value of Liver Enzymes and Inflammatory Biomarkers for the Severity of Liver Fibrosis Stage in HIV/HCV Co-Infected Patients (2013) (12)
- Care of hepatitis C virus infection in human immunodeficiency virus-infected patients: modifications in three consecutive large surveys between 2004 and 2009. (2010) (12)
- Trends in Condom Use and Risk Behaviours after Sexual Exposure to HIV: A Seven-Year Observational Study (2014) (12)
- Herpes Simplex Virus Meningoencephalitis in a Patient With Crohn's Disease on Azathioprine Therapy (2010) (12)
- Innate immune deficiencies are associated with severity and poor prognosis in patients with COVID-19 (2022) (12)
- CD4+ T-cell-guided structured treatment interruptions of antiretroviral therapy in HIV disease: Projecting beyond clinical trials (2010) (12)
- Factors associated with satisfaction with community-based non-medicalized counseling and testing using HIV rapid tests among MSM in France (2016) (12)
- HIV-serodiscordant couples desiring a child: 'treatment as prevention,' preexposure prophylaxis, or medically assisted procreation? (2015) (12)
- Breakthrough infections after post-exposure vaccination against Monkeypox (2022) (11)
- Central nervous system HIV replication and HIV-related pachymeningitis in a patient on protease inhibitor monotherapy despite an undetectable plasma viral load. (2012) (11)
- Natural polymorphisms in HIV‐1 protease: Impact on effectiveness of a first‐line lopinavir‐containing antiretroviral therapy regimen (2008) (11)
- Foscarnet, zidovudine and dolutegravir combination efficacy and tolerability for late stage HIV salvage therapy: A case‐series experience (2016) (11)
- Time to initiation of antiretroviral therapy in HIV‐infected patients diagnosed with an opportunistic disease: a cohort study (2015) (10)
- Atazanavir in Patients with Persistent Viral Replication Despite HAART: Results from the French Prospective NADIS Cohort (2008) (10)
- Epidemiology and control of SARS-CoV-2 epidemics in partially vaccinated populations: a modeling study applied to France (2022) (10)
- Vaccination and blood sampling acceptability during Ramadan fasting month: A cross-sectional study in Conakry, Guinea. (2017) (10)
- Drug assessment in the Ebola virus disease epidemic in west Africa. (2015) (9)
- Accelerating clinical trial implementation in the context of the COVID-19 pandemic: challenges, lessons learned and recommendations from DisCoVeRy and the EU-SolidAct EU response group (2021) (9)
- [Quality of life in chronic inflammatory bowel diseases. Validation of a questionnaire and first French data]. (1996) (9)
- ABCB1 Allele Polymorphism Is Associated with Virological Efficacy in Naïve HIV-Infected Patients on HAART Containing Nonboosted PIs But Not Boosted PIs (2008) (9)
- Prescribers' experience and opinions on antimicrobial stewardship programmes in hospitals: a French nationwide survey. (2019) (9)
- Infection par le virus Zika chez la femme enceinte (2016) (9)
- HCV-Related Mortality Among HIV/HCV Co-infected Patients: The Importance of Behaviors in the HCV Cure Era (ANRS CO13 HEPAVIH Cohort) (2019) (9)
- High virological suppression regardless of the genotypic susceptibility score after switching to a dolutegravir-based regimen: week 48 results in an observational cohort (2018) (9)
- Illicit massive silicone injections always induce chronic and definitive silicone blood diffusion with dermatologic complications (2019) (9)
- Development of a Prediction Model for Ebola Virus Disease: A Retrospective Study in Nzérékoré Ebola Treatment Center, Guinea. (2016) (9)
- Empirical therapies among adults hospitalized for community-acquired upper urinary tract infections: A decision-tree analysis of mortality, costs, and resistance. (2015) (9)
- Tolerability of fosamprenavir/ritonavir associated with zidovudine-lamivudine used as postexposure prophylaxis for HIV infection. (2008) (9)
- Predictors of return rate for an HIV-positive result in a French Voluntary Counseling and Testing centre (2015) (9)
- Virological outcome at week 48 of three recommended first-line regimens using ultrasensitive viral load and plasma drug assay. (2014) (9)
- A race between SARS-CoV-2 variants and vaccination: The case of the B.1.1.7 variant in France (2021) (9)
- COVID-19 vaccines: A race against time (2021) (9)
- Spondylodiscitis and an aortic aneurysm due to Campylobacter coli (2010) (9)
- Increased bleeding in HIV-positive haemophiliac patients treated with lopinavir–ritonavir (2003) (9)
- P0795 : Safety and efficacy of sofosbuvir-containing regimens in the French observational cohort ANRS CO22 HEPATHER (2015) (9)
- Week 96 efficacy of lopinavir/ritonavir monotherapy in virologically suppressed patients with HIV: a randomized non-inferiority trial (ANRS 140 DREAM) (2018) (9)
- Calendar trends in sexual behaviours in a cohort of HIV-infected MSM at the era of treatment as prevention of HIV infection (2018) (8)
- Lopinavir/ritonavir resistance in patients infected with HIV‐1: two divergent resistance pathways? (2011) (8)
- Are targeted treatment recommendations in chronic hepatitis C tailored to diagnostic methods of fibrosis? (2017) (8)
- Pharmacokinetic modelling of darunavir/ritonavir dose reduction (800/100 to 400/100 mg once daily) in a darunavir/ritonavir-containing regimen in virologically suppressed HIV-infected patients: ANRS 165 DARULIGHT sub-study (2018) (8)
- Self-testing and vaccination against COVID-19 to minimize school closure (2021) (8)
- Major amputation of lower extremity: prognostic value of positive bone biopsy cultures. (2013) (8)
- Aspergillus flavus malignant external otitis in a diabetic patient: case report and literature review (2020) (8)
- Risk factors for grade 3 or 4 gamma-glutamyl transferase elevation in HIV/hepatitis C virus-coinfected patients. (2008) (8)
- A 4-days-on and 3-days-off maintenance treatment strategy for adults with HIV-1 (ANRS 170 QUATUOR): a randomised, open-label, multicentre, parallel, non-inferiority trial. (2022) (8)
- Hand hygiene improvement or antibiotic restriction to control the household transmission of extended-spectrum β-lactamase-producing Escherichia coli: a mathematical modelling study (2020) (8)
- COVID-19: France grapples with the pragmatics of isolation (2020) (8)
- Brain abscesses during Proteus vulgaris bacteremia (2011) (8)
- Switch as maintenance to elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate: week 48 results in a clinical cohort (2017) (8)
- Effectiveness and cost of quick diagnostic tests to determine tetanus immunity in patients with a wound in french emergency departments (2014) (8)
- Early hepatocellular carcinoma detection using magnetic resonance imaging is cost-effective in high-risk patients with cirrhosis (2021) (8)
- LB4. A Phase 3, Randomized, Controlled Clinical Trial of Bictegravir in a Fixed-Dose Combination, B/F/TAF, vs. ABC/DTG/3TC in Treatment-Naïve Adults at Week 96 (2018) (8)
- Strengthening capacity for clinical research in sub-Saharan Africa: partnerships and networks. (2021) (8)
- Disparities in HIV‐1 transmitted drug resistance detected by ultradeep sequencing between men who have sex with men and heterosexual populations (2017) (8)
- Is detection of JC virus DNA in blood a valuable screening test for progressive multifocal leukoencephalopathy in Crohn's disease patients eligible for anti-alpha4 integrin therapy? (2008) (8)
- Breakthrough Infections after Postexposure Vaccination against Mpox. (2022) (8)
- HIV-1 protease, Gag and gp41 baseline substitutions associated with virological response to a PI-based regimen. (2019) (8)
- Pharmacokinetic modelling of darunavir/ritonavir dose reduction (800/100 to 400/100 mg once daily) in a darunavir/ritonavir-containing regimen in virologically suppressed HIV-infected patients: ANRS 165 DARULIGHT sub-study (2018) (8)
- Patient-reported symptoms during direct-acting antiviral treatment: A real-life study in HIV-HCV coinfected patients (ANRS CO13 HEPAVIH). (2020) (7)
- Kaposi's sarcoma in HIV-infected patients: when and how should we evaluate bone involvement? (2007) (7)
- Metabolic syndrome and endocrine status in HIV-infected transwomen (2019) (7)
- Understanding the long-term evolution and predictors of sequelae of Ebola virus disease survivors in Guinea: A 48-month prospective, longitudinal cohort study (PostEboGui). (2021) (7)
- Enrolling study personnel in Ebola vaccine trials: from guidelines to practice in a non-epidemic context (2019) (7)
- Short communication: Prevalence of HIV-1 transmitted drug resistance in Liberia. (2014) (7)
- Challenges of data sharing in European Covid-19 projects: A learning opportunity for advancing pandemic preparedness and response (2022) (7)
- O85 SHOULD WE AWAIT INTERFERON-FREE REGIMENS TO TREAT HCV GENOTYPE 1 TREATMENT-NAIVE PATIENTS? A COST-EFFECTIVENESS ANALYSIS (ANRS 12188) (2014) (7)
- Estimating the Time to Diagnosis and the Chance of Spontaneous Clearance During Acute Hepatitis C in Human Immunodeficiency Virus-Infected Individuals (2017) (7)
- Efficacy, Safety, and Durability of Long-Acting Cabotegravir and Rilpivirine in Adults With Human Immunodeficiency Virus Type 1 Infection: 5-Year Results From the LATTE-2 Study (2021) (7)
- Prise en charge de l'infection à VIH en 2005 en France à travers 7416 patients de la cohorte NADIS (2006) (7)
- Risk Factors of Chronic Kidney Disease in (2011) (7)
- Manifestations pulmonaires au cours de l’infection par le VIH : démarche diagnostique (2014) (7)
- Correction: Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea (2016) (7)
- A Case of Aggregatibacter aphrophilus Multiple Abscess (2015) (7)
- Markov modelling of HIV infection evolution in the HAART era (2009) (7)
- Skin and soft tissue infections due to Panton-Valentine leukocidin producing Staphylococcus aureus. (2012) (7)
- [The plague: An overview and hot topics]. (2018) (7)
- [An update on measles]. (2015) (7)
- Cohorte Nadis : 6236 patients séropositifs suivis dans des CHU de France (2005) (7)
- Kaposi sarcoma among people living with HIV in the French DAT’AIDS cohort between 2010 and 2015 (2020) (7)
- Cost-effectiveness of vaccination against cytomegalovirus (CMV) in adolescent girls to prevent infections in pregnant women living in France. (2018) (6)
- [Medical care for HIV infection in France in 2005, the NADIS cohort study on 7416 patients]. (2006) (6)
- Preparing for a pandemic: highlighting themes for research funding and practice—perspectives from the Global Research Collaboration for Infectious Disease Preparedness (GloPID-R) (2020) (6)
- A decision tree to help determine the best timing and antiretroviral strategy in HIV-infected patients (2011) (6)
- Incidence of and risk factors for medical care interruption in people living with HIV in recent years (2019) (6)
- It is time to change the paradigm for hepatitis C virus testing. (2012) (6)
- Microelimination or not? The changing epidemiology of HIV-HCV coinfection in France 2012-2018. (2021) (6)
- Long-term plasma pharmacokinetics of bedaquiline for multidrug- and extensively drug-resistant tuberculosis. (2019) (6)
- Population pharmacokinetics of Rilpivirine in HIV-1-infected patients treated with the single-tablet regimen rilpivirine/tenofovir/emtricitabine (2018) (6)
- Impact of ART classes on the increasing risk of cerebral small-vessel disease in middle-aged, well-controlled, cART-treated, HIV-infected individuals. (2019) (6)
- Pharmacovirological analyses of blood and male genital compartment in patients receiving dolutegravir + lamivudine dual therapy as a switch strategy (ANRS 167 LAMIDOL trial). (2020) (6)
- Prolonged Hospital Stay, an Adverse Effect of Strict National Policy for Controlling the Spread of Highly Resistant Microorganisms (2014) (6)
- Multimorbidity in Elderly Subjects according to the year of diagnosis of HIV-Infection - A Cross-Sectional DATAIDS Cohort Study. (2019) (6)
- Partnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countries (2020) (6)
- Partnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countries (2020) (6)
- La peste : mise au point et actualités (2018) (6)
- Final results of the DisCoVeRy trial of remdesivir for patients admitted to hospital with COVID-19 (2022) (6)
- HIV testing in Europe: Evaluating the impact, added value, relevance and usability of the European Centre for Disease Prevention and Control (ECDC)’s 2010 HIV testing guidance (2017) (6)
- [Are the principles of treatment of chronic osteitis applicable to the diabetic foot?]. (2002) (6)
- Pharmacologic Boosting of Atazanavir in Maintenance HIV-1 Therapy: The COREYA Propensity-Score Adjusted Study (2012) (6)
- Mitral endocarditis due to Rothia aeria with cerebral haemorrhage and femoral mycotic aneurysms, first French description (2016) (6)
- New mechanisms of resistance in virological failure to protease inhibitors: selection of non-described protease, Gag and Gp41 mutations. (2019) (6)
- Genetic barrier for attachment inhibitor BMS-626529 resistance in HIV-1 B and non-B subtypes. (2015) (6)
- Characteristics and consequences of medical care interruptions in HIV-infected patients in France (2016) (5)
- 8th IAS Conference on HIV Pathogenesis, Treatment & Prevention 19–22 July 2015, Vancouver, Canada (2015) (5)
- Is expert opinion reliable when estimating transition probabilities? The case of HCV-related cirrhosis in Egypt (2014) (5)
- Innate immune deficiencies in patients with COVID-19 (2021) (5)
- Score for pulmonary tuberculosis in patients with clinical presumption of tuberculosis in a low-prevalence area. (2017) (5)
- Generic antiretroviral drugs and HIV care: An economic review. (2016) (5)
- Analysis of Costs Attributable to an Outbreak of Severe Acute Respiratory Syndrome at a French Hospital (2006) (5)
- Current guidelines and prioritizing treatment of hepatitis C virus in HIV-infected patients (2015) (5)
- 1155 Efficacy of tenofovir disoproxil fumarate (TDF) for hepatitis B virus (HBV) in human immunodeficiency virus (HIV) infected patients (2003) (5)
- Temporal evolution of the humoral antibody response after Ebola virus disease in Guinea: a 60-month observational prospective cohort study. (2021) (5)
- Grazoprevir/elbasvir for the immediate treatment of recently acquired HCV genotype 1 or 4 infection in MSM. (2020) (5)
- Hépatite C : transmission nosocomiale, état de santé et devenir des personnes atteintes (2003) (5)
- Factors associated with virological response to a switch regimen containing maraviroc for antiretroviral-experienced HIV-1-infected patients. (2016) (5)
- Clinical trial protocols of repurposed prophylaxis for COVID-19: A review (2020) (5)
- Mean cost of a first combination antiretroviral therapy in HIV-infected patients in France, and determinants of expensive drugs prescription (2012) (5)
- Management of oral antiretroviral administration in patients with swallowing disorders or with an enteral feeding tube. (2019) (5)
- Co-infection avec les hépatites virales (2007) (5)
- Risk Factors Associated with Severe/Critical COVID-19 in People Living with HIV-1 (2022) (5)
- Low-dose ritonavir-boosted darunavir in virologically suppressed HIV-1-infected adults: an open-label trial (ANRS 165 Darulight) (2018) (5)
- [Non-cutaneous manifestations of secondary syphilis]. (2008) (5)
- Actualité de la rougeole (2015) (5)
- Role of Baseline HIV-1 DNA Level in Highly-Experienced Patients Receiving Raltegravir, Etravirine and Darunavir/Ritonavir Regimen (ANRS139 TRIO Trial) (2013) (5)
- Corrigendum to “SHORT STATEMENT OF THE FIRST EUROPEAN CONSENSUS CONFERENCE ON THE TREATMENT OF CHRONIC HEPATITIS B AND C IN HIV CO-INFECTED PATIENTS”[J Hepatol 42 (2005) 615–624] (2005) (5)
- Cost-effectiveness of HIV therapies in resource-poor countries. (2003) (5)
- [Retrospective study of 106 cases of varicella in immunocompetent adults. Parameters associated with varicella pneumonia]. (2009) (5)
- Enterobacteriaceae bacteremia: risk factors for ESBLPE. (2014) (5)
- After 2 years of the COVID-19 pandemic, translating One Health into action is urgent (2022) (5)
- Isoniazid-monoresistant tuberculosis in France: risk factors, treatment outcomes and adverse events. (2021) (5)
- Concentration-response model of rilpivirine in a cohort of HIV-1-infected naive and pre-treated patients. (2019) (5)
- Sub-Saharan African migrants have slower initial CD4+ cell recovery after combined antiretroviral treatment initiation than French natives. (2017) (4)
- Assessing characteristics of hidden epidemics to design the most efficient HIV testing strategies. (2014) (4)
- 48 week bone marker changes with Dolutegravir (DTG) plus Abacavir/Lamivudine (ABC/3TC) vs. Tenofovir/Emtricitabine/Efavirenz (EFV/TDF/FTC): the SINGLE trial (2014) (4)
- Left Ventricular Assist Pump Pocket Infection: Conservative Treatment Strategy for Destination Therapy Candidates (2017) (4)
- Épidémie de légionellose dans le Pas-de-Calais (2003-2004) : analyse descriptive et facteurs prédictifs d’une évolution défavorable (2008) (4)
- Les antirétroviraux ont-ils une place dans le traitement du syndrome respiratoire aigu sévère ? (2006) (4)
- The effectiveness of indicator disease-based HIV testing across Europe - results from a prospective multi-centre study (2015) (4)
- Double dispensation des antirtroviraux en ville : bilan un an dans l'agglomration lilloise (2001) (4)
- Multidrug resistance: a clinical approach (2009) (4)
- Volumineux abcès hépatiques secondaires à une bactériémie à Streptococcus constellatus en rapport avec une diverticulose compliquée (2003) (4)
- Multicenter study on recent portal venous system thrombosis associated with cytomegalovirus disease. (2021) (4)
- Impact of test-and-treat and risk reduction strategies on HCV transmission among MSM living with HIV in France: a modelling approach (2020) (4)
- Myocarditis in monkeypox-infected patients: a case series (2022) (4)
- Cytopathies mitochondriales au cours de l’infection par le VIH (2006) (4)
- Costs associated with hospitalization in HIV-positive patients in France (2018) (4)
- Primo-infection toxoplasmique avec atteinte pulmonaire chez un immunocompétent (2010) (4)
- Clinical Impact and Cost-Effectiveness of Making Third-Line Antiretroviral Therapy Available in Sub-Saharan Africa: A Model-Based Analysis in Côte d'Ivoire (2014) (4)
- Contribution of brain imaging to the diagnosis of intracranial tuberculoma and other brain lesions in patients presenting with miliary tuberculosis. (2018) (4)
- Serious neuropsychiatric adverse effects related to interaction between itraconazole and darunavir/ritonavir in an HIV-infected patient with cerebral histoplasmosis (2018) (4)
- [Primary pulmonary toxoplasmosis in an immunocompetent patient]. (2010) (4)
- Syndrome respiratoire aigu sévère (2003) (4)
- High-risk exposure without personal protective equipment and infection with SARS-CoV-2 in healthcare workers: results of the CoV-CONTACT prospective cohort (2020) (4)
- Bon usage de la ticoplanine dans les infections osto-articulaires (2004) (4)
- P0745 : EQ-5D utility index in French patients with chronic hepatits C (CHC) infection: severe comorbidities and perceived progression of CHC infection matter more than actual liver disease stage (2015) (4)
- Effect of remdesivir on viral dynamics in COVID-19 hospitalized patients: a modelling analysis of the randomized, controlled, open-label DisCoVeRy trial (2022) (4)
- How Long Do Physicians Wait to Start Antiretroviral Treatment in Newly Diagnosed HIV-Infected Patients? (2011) (4)
- Caractéristiques démographiques, cliniques, immunovirologiques et thérapeutiques de 8714 patients infectés par le VIH de la cohorte Nadis en 2006 (2008) (4)
- Lack of a Clinically Significant Pharmacokinetic Interaction between Etravirine and Raltegravir Using an Original Approach Based on Drug Metabolism, Protein Binding, and Penetration in Seminal Fluid: A Pharmacokinetic Substudy of the ANRS‐163 ETRAL Study (2019) (4)
- O89 IMPACT OF NEW DAA-CONTAINING REGIMENS ON HCV TRANSMISSION AMONG INJECTING DRUG USERS (IDUS): A MODEL-BASED ANALYSIS (ANRS 12376) (2014) (4)
- Antiretroviral-Experienced HIV-1-Infected Patients Treated with Maraviroc: Factors Associated with Virological Response. (2015) (4)
- Contributions and challenges of community pharmacists during the COVID-19 pandemic: a qualitative study (2022) (4)
- Evolution of outcomes for patients hospitalized during the first SARS-CoV-2 pandemic wave in France (2020) (3)
- Occupational transmission of hepatitis C virus resulting from use of the same supermarket meat slicer. (2011) (3)
- Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19 (2023) (3)
- “Advancing preparedness for clinical research during infectious disease epidemics” Nina Gobat, John Amuasi, Yazdan Yazdanpanah, Louise Sigfrid, Hugh Davies, John-Paul Byrne, Gail Carson, Christopher Butler, Alistair Nichol and Herman Goossens. ERJ Open Res 2019; 5: 00227-2018. (2019) (3)
- Ebola: should we consider influenza vaccination? (2014) (3)
- Late diagnosis and subsequent survival among HIV-infected truck drivers in the northwest of France: a retrospective study (2009) (3)
- French research strategy to tackle antimicrobial resistance (2020) (3)
- Impact of the COVID-19 pandemic on the homeless: results from a retrospective closed cohort in France (March–May 2020) (2021) (3)
- Response to comment on article by Jit et al. The cost effectiveness of rotavirus vaccination: Comparative analyses for five European countries and transferability in Europe (2011) (3)
- Hydatidose pulmonaire : prise en charge médicochirurgicale (2004) (3)
- First case of intrafamily transmission of a new MRSA clone with toxic shock syndrome toxin-1 (2008) (3)
- Durability and Effectiveness of Maraviroc-Containing Regimens in HIV-1-Infected Individuals with Virological Failure in Routine Clinical Practice (2015) (3)
- High-risk exposure without personal protective equipment and infection with SARS-CoV-2 in-hospital workers - The CoV-CONTACT cohort (2021) (3)
- Congenital Leishmaniasis in a Newborn Infant Whose Mother was Coinfected With Leishmaniasis and HIV. (2020) (3)
- [Multiple liver abscesses caused by Streptococcus constellatus in association with diverticulitis]. (2003) (3)
- Pneumonie chez un voyageur au retour d’Asie (2008) (3)
- Hepatitis C virus (HCV) incidence among men who have sex with men (MSM) living with HIV: results from the French Hospital Database on HIV (ANRS CO4-FHDH) cohort study, 2014 to 2017 (2021) (3)
- Engager (avec) les communautés dans un essai vaccinal en contexte post-Ebola (Guinée Conakry) : un modèle basé sur les « champions » (2018) (3)
- Pyélonéphrite chronique et pyélonéphrite xanthogranulomateuse (2011) (3)
- No relationship between late HIV diagnosis and social deprivation in newly diagnosed patients in France (2018) (3)
- P0468 : Negative impact of HBV/HCV coinfection on HBV or HCV monoinfection: Data from the French cohort – ANRS CO22 hepather (2015) (3)
- Review and methodological analysis of trials currently testing treatment and prevention options for the novel coronavirus disease (COVID-19) globally. (2020) (3)
- CD177, a specific marker of neutrophil activation, is a hallmark of COVID-19 severity and death (2020) (3)
- Delayed management of Staphyloccocus aureus infective endocarditis in a Middle East respiratory syndrome coronavirus possible case hospitalized in 2015 in Paris, France (2016) (3)
- Fair prices for new direct-acting antiviral agents (DAAs) to make treatment for all affordable (2015) (3)
- [Demographic, clinical, immunovirological and therapeutic features of 8714 HIV infected French patients included in the Nadis Hospital Cohorte in 2006]. (2008) (3)
- Adult-onset Still's disease in a patient with human immunodeficiency virus infection: pathophysiological link? (2020) (3)
- Are European-specific guidelines needed for prevention of opportunistic infections in HIV-1? (1999) (3)
- Lockdown as a last resort option in case of COVID-19 epidemic rebound: a modelling study (2021) (3)
- Revised Definitions of Tuberculosis Resistance and Treatment Outcomes, France, 2006–2019 (2022) (3)
- Factors associated with being overweight and obesity in people living with HIV on antiretroviral therapy : socio-clinical, inflammation, and metabolic markers. (2021) (3)
- Vancomycin flush as antibiotic prophylaxis for early catheter-related infections: a cost-effectiveness analysis (2009) (3)
- Voluntary Community Human Immunodeficiency Virus Testing, Linkage, and Retention in Care Interventions in Kenya: Modeling the Clinical Impact and Cost-effectiveness (2018) (3)
- [Granular cell tumor of the choledochus]. (1993) (3)
- Epidemiological Profile of Newly Diagnosed HIV-Infected Patients in Northern Paris: A Retrospective Study. (2016) (3)
- Cholangitis in three critically ill patients after a severe CoVID-19 infection (2021) (3)
- Investigating Recent Testing among MSM: Results from Community-Based HIV Rapid Testing Attendees in France (2013) (3)
- Randomized Trial of Vaccines for Zaire Ebola Virus Disease. (2022) (3)
- Use of fluoroquinolones for the treatment of TB: 8 years of experience. (2015) (3)
- [Abdominal emergencies and Von Recklinghausen neurofibromatosis]. (1997) (3)
- Screening and vaccination against COVID-19 to minimize school closure (2021) (3)
- Use of PCR Signal and Therapeutic Drug Monitoring in a Switch Cohort Study to Tenofovir/Emtricitabine/Rilpivirine: A W96 Follow-Up (2015) (3)
- [Pulmonary manifestations in HIV-infected patients: a diagnostic approach]. (2014) (3)
- Corrigendum to ‘detection of SARS-CoV-2 N-antigen in blood during acute COVID-19 provides a sensitive new marker and new testing alternatives’ (2021) (3)
- [The Nadis cohort: 6236 HIV-infected patients followed up in French university hospitals]. (2005) (2)
- International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK (2016) (2)
- Islatravir safety analysis through week 48 from a phase 2 trial in treatment naive adults with HIV-1 infection (2020) (2)
- [CCR5 antagonists: a new class of antiretrovirals]. (2008) (2)
- Pneumonie à Pasteurella multocida compliquée de choc septique chez un patient non immunodéprimé (2007) (2)
- Late viral or bacterial respiratory infections in lung transplanted patients: impact on respiratory function (2020) (2)
- Drug efficacy by direct and adjusted indirect comparison to placebo: An illustration by Mycobacterium avium complex prophylaxis in HIV (2011) (2)
- Cas groupés de fièvre typhoïde autochtone dans une agglomération française (2011) (2)
- COL3-01 Cohorte Nadis ® 2008 : caractéristiques cliniques, biologiques et thérapeutiques des 12 198 patients (2009) (2)
- Sociodemographic characteristics and transmission risk factors in patients hospitalized for COVID-19 before and during the lockdown in France (2020) (2)
- Facteurs de risque de transmission accidentelle du VHC au personnel soignant au décours d'un accident exposant au sang: une étude cas-témoins européenne (2006) (2)
- [Adequate use of teicoplanin in bone and joint infections]. (2004) (2)
- Remdesivir for the Treatment of Hospitalised Patients with COVID-19 (DisCoVeRy): A Randomised, Controlled, Open-Label Trial (2021) (2)
- [Antiretroviral drugs in severe acute respiratory syndrome]. (2006) (2)
- K-02 Comparaison des associations rifampicineclindamycine et rifampicine-ofloxcine dans le traitement des infections ostéo-articulaires staphylococciques sur matériel orthopédique (2009) (2)
- What is a modest public health impact? (2012) (2)
- Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial—authors’ response (2020) (2)
- Switching from boosted PIs to dolutegravir in HIV-infected patients with high cardiovascular risk: 48 week effects on subclinical cardiovascular disease. (2020) (2)
- Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial—authors’ response (2020) (2)
- SARS-CoV-2 N-antigenemia: A new alternative to nucleic acid amplification techniques (2020) (2)
- [Mitochondrial cytopathies associated with HIV infection]. (2006) (2)
- Absence of infection in asymptomatic contacts of index SARS case in France. (2006) (2)
- 1362 THE AVAILABILITY OF DIRECT ACTING ANTIVIRALS (DAA) IN 2012: A FRENCH MODEL-BASED ANALYSIS OF THE INCREASED NUMBER OF PATIENTS TREATED FOR CHRONIC HCV INFECTION (2011) (2)
- [Pneumonia in a traveller coming back from Asia]. (2008) (2)
- Usefulness of therapeutic drug monitoring of rilpivirine and its relationship with virologic response and resistance in a cohort of naive and pretreated HIV‐infected patients (2020) (2)
- Can the “Seek, Test, Treat, and Retain” Strategy be Effective in France? (2013) (2)
- [Cluster of indigenous typhoid fever cases in a French city]. (2011) (2)
- A Healthcare-Associated Infection With Monkeypox Virus of a Healthcare Worker During the 2022 Outbreak (2022) (2)
- Increased linezolid plasma concentrations are associated with the development of severe toxicity in MDR-TB treatment. (2022) (2)
- Les maladies émergentes (2016) (2)
- Sub-Saharan Africa migrants have slower initial CD4 cell recovery after cART initiation than French natives, regardless of living conditions. (2017) (2)
- Dynamic modelling of HCV transmission among drug users: a methodological review (2013) (2)
- Incidence and risk factors for medical care interruption in people living with HIV in a French provincial city (2020) (2)
- A case of thoracic actinomycosis presenting as sudden paraplegia. (2018) (2)
- [Distribution of antimicrobial guidelines: useful but not enough for an antibiotic stewardship]. (2014) (2)
- Evaluation médico-économique en santé : Prophylaxie des infections opportunistes chez les patients infectés par le virus d'immunodéficience humaine (VIH) : coût-efficacité des statégies préconisées par les recommandations françaises (2002) (2)
- Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial (2023) (2)
- Neutralizing antibodies against SARS-CoV-2 variants following mRNA booster vaccination in adults older than 65 years (2022) (2)
- Iconographies supplémentaires de l'article : Plague: Bridging gaps towards better disease control (2018) (2)
- Low serum neutralization of Omicron variants a month after AZD7442 prophylaxis initiation (2022) (2)
- Impact of sex on hepatitis C virus transmission: conflicting results. (2006) (2)
- 809 IMMEDIATE OR DELAYED TREATMENT INITIATION WITH “PREVIR” CONTAINING REGIMENS IN HCV-INFECTED NAIVE GENOTYPE 1 (G1) PATIENTS WITHOUT SEVERE FIBROSIS? A COST-EFFECTIVENESS ANALYSIS (ANRS N°12188) (2013) (2)
- 885 IMMEDIATE vs. DELAYED TREATMENT IN GENOTYPE 4-HCV INFECTED PATIENTS IN A LIMITED RESOURCES COUNTRY: A COST-EFFECTIVENESS ANALYSIS IN EGYPT (ANRS 12215) (2013) (2)
- Infection primaire de prothse vasculaire salmonelle et traitement conservateur (2008) (1)
- Raltegravir 1200 mg once daily as maintenance therapy in virologically suppressed HIV-1 infected adults: QDISS open-label trial (2021) (1)
- 18FDG-PET/CT: a useful tool for the management of patients in infectious diseases (2017) (1)
- Tuberculosis treatment outcomes among precarious patients in france. (2022) (1)
- Maladie à virus Ebola : actualités thérapeutiques (2016) (1)
- [Factors predicting mortality during an outbreak of Legionnaire's disease in the north of France]. (2008) (1)
- HIV Infection in North African Patients. (2019) (1)
- Actualités scientifiques (2020) (1)
- Infection à VIH, infections sexuellement transmises et complications dermatologiques chez les sujets transgenres consultant en centre hospitalo-universitaire. Résultats préliminaires chez 399 patients (2015) (1)
- COL2-03 Facteurs de risque de perte de vue dans une cohorte de patients infectés par le VIH suivis dans le Nord Pas-de-Calais (2008) (1)
- Voluntary HIV and Viral Hepatitis Testing in Newly Arrived Migrant Men in a First Reception Center in the North of Paris—a Qualitative Study on the Perception and Forms of Participation (2021) (1)
- Re-treatment of chronic HCV infection in HIV co-infected patients and predictors of sustained viral response. (2014) (1)
- A-09 Méningo-encéphalite herpétique de l'adulte dans la région nord-pas-de-calais. Étude descriptive et recherche de facteurs prédictifs de mortalité (2004) (1)
- Les ostéopathies fragilisantes des patients infectés par le VIH (2009) (1)
- Les inhibiteurs de CCR5 : une nouvelle classe d’antirétroviraux (2008) (1)
- Prévalence de prescriptions de sérologies de l’hépatite B et de vaccins contre l’hépatite B en médecine générale, une étude à partir de l’EGB du SNIIRAM (2017) (1)
- Track E Implementation Science, Health Systems and Economics (2012) (1)
- : influenza A ( H 1 N 1 ) virus in patients with inflammatory bowel disease (2009) (1)
- Increased risk of severe COVID-19 in hospitalized patients with SARS-CoV-2 Alpha variant infection: a multicentre matched cohort study (2022) (1)
- Jaundice in a patient treated with Anakinra in a context of Covid-19 (2020) (1)
- Characterization of viral rebounds on dual etravirine/raltegravir maintenance therapy (ANRS-163 ETRAL trial). (2020) (1)
- [HIV infection]. (2012) (1)
- Living conditions, HIV and gender affirmation care pathways of transgender people living with HIV in France: a nationwide, comprehensive, cross-sectional, community-based research protocol (ANRS Trans&HIV) (2021) (1)
- Health status and health care trajectory of vulnerable asylum seekers hosted in a French Reception Center. (2021) (1)
- HIV treatment decision making: high rate of revised treatment choices based upon different genotypic interpretation systems (2008) (1)
- Respiratory support in patients with severe COVID-19 in the International Severe Acute Respiratory and Emerging Infection (ISARIC) COVID-19 study: a prospective, multinational, observational study (2022) (1)
- [Mycobacterium abscessus pulmonary infection treated with tigecyclin-amikacin and cefoxitin in a diabetic patient]. (2011) (1)
- CD177, a specific marker of neutrophil activation, is associated with coronavirus disease 2019 severity and death (2022) (1)
- Chronicles of a pandemic: How France coordinated the scientific research response to COVID-19 (2021) (1)
- Pre-exposure HIV prophylaxis (PrEP) among transgender women: 3 years of follow-up in a university hospital in Paris (2020) (1)
- Étude rétrospective de 17 cas de DRESS chez des patients infectés par le VIH : DRESS ou VRESS ? (2015) (1)
- Effects of remdesivir in patients hospitalised with COVID-19: a systematic review and individual patient data meta-analysis of randomised controlled trials (2023) (1)
- Tuberculose multirésistante sur site d’injections de silicone chez un sujet transgenre infecté par le VIH. Premier cas décrit☆ (2015) (1)
- Transmission of SARS-CoV-2 during indoor clubbing events: A clustered randomized, controlled, multicentre trial protocol (2022) (1)
- Earlier In Vitro Viral Production With SARS-CoV-2 Alpha Than With Beta, Gamma, B, or A.27 Variants (2021) (1)
- Risk factors for hepatitis C virus transmission to health care workers after occupational exposure: a European case-control study. (2005) (1)
- Treatment as prevention (TasP) and perceived sexual changes in behavior among HIV-positive persons: a French survey in infectious diseases departments in Paris (2020) (1)
- Symptom‐based case definitions for COVID‐19: Time and geographical variations for detection at hospital admission among 260,000 patients (2022) (1)
- Incidence et facteurs associés aux interruptions de soins médicaux dans une cohorte de patients infectés par le VIH (2017) (1)
- [Pneumonia with septicemia caused by Pasteurella multocida in an immunocompetent patient]. (2007) (1)
- Mathematical modeling: a tool for selecting agents with complementary modes of action? (2013) (1)
- Infectious Complications After the Use of Angioseal Closure Device for Femoral Artery: About 2 Cases (2009) (1)
- Cost-effectiveness of scaling-up treatment with nucleoside analogue (NA) for chronic HBV infection: Towards a simplification of recommendations? (ANRS study) (2020) (1)
- Brief Report: Efficacy and Safety of Oral Islatravir Once Daily in Combination With Doravirine Through 96 Weeks for Treatment-Naive Adults With HIV-1 Infection Receiving Initial Treatment With Islatravir, Doravirine, and Lamivudine (2021) (1)
- The Global Fund in the era of SDGs: time to rethink? (2020) (1)
- Assessing the evidence on remdesivir (2021) (1)
- Treatment With a Three-Drug Regimen for Pulmonary Tuberculosis Based on Rapid Molecular Detection of Isoniazid Resistance: A Noninferiority Randomized Trial (FAST-TB) (2022) (1)
- STATEMENT OF THE FIRST EUROPEAN CONSENSUS CONFERENCE ON THE TREATMENT OF CHRONIC HEPATITIS B AND C IN HIV CO-INFECTED PATIENTS * (2005) (1)
- HCV cure: an appropriate moment to reduce cannabis use in people living with HIV? (ANRS CO13 HEPAVIH data) (2022) (1)
- Infection pulmonaire à Mycobacterium abscessus chez une patiente diabétique traitée par l’association tigécycline-amikacine-céfoxitime (2011) (1)
- Ledipasvir/Sofosbuvir in NS3/4A Protease Inhibitor-Experienced Subjects with HCV Genotype 1 and HIV-Co-Infection Final Results of the ANRS HC31 Softrih Study (2016) (1)
- Patient-centered approach to the management of drug-resistant tuberculosis in France: How far off the mark are we? (2022) (1)
- Chronic use of renin‐angiotensin‐aldosterone system blockers and mortality in COVID‐19: A multicenter prospective cohort and literature review (2021) (1)
- [Primary Salmonella vascular graft infection and conservative treatment]. (2008) (1)
- Absence of infection in asymptomatic contacts of index SARS case in France. (2006) (1)
- No barrier to care, yet disparities in the HIV care continuum in France: a nationwide population study. (2021) (1)
- Quelles sont les conséquences de l’épidémie COVID-19 sur l’organisation des soins ? (2020) (1)
- The acceptability and effectiveness of a questionnaire for the identification of risk factors for HIV and hepatitis B and C: An observational study in general practice (2017) (1)
- Influence de la distribution d’un référentiel anti-infectieux sur la prise en charge des bactériémies : utile mais pas suffisante (2014) (1)
- Intérêt de la quantification par PCR de l’ADN du VHB chez les patients traités par lamivudine (2002) (1)
- Efficacy and tolerability of combined antiretroviral treatment with bictegravir/emtricitabine/tenofovir alafenamide initiated at the time of primary HIV infection. (2021) (1)
- Ending COVID-19: progress and gaps in research—highlights of the July 2020 GloPID-R COVID-19 Research Synergies Meetings (2020) (1)
- Quelles sont les conséquences de l’épidémie COVID-19 sur les personnels de santé ? (2020) (1)
- Skeletal muscle toxicity associated with emtricitabine/rilpivirine/tenofovir fixed-dose combination: a case report. (2014) (1)
- HIV Prevention and Care of Transgender Women in an HIV and STI Clinic in the Paris Metropolitan Area (2020) (1)
- Cost-effectiveness of HIV Antiretroviral Therapies in Resource-limited Settings (2008) (1)
- Quantitative methods used to evaluate impact of health promotion interventions to prevent HIV infections: a methodological systematic review protocol (2021) (1)
- Modelling the end of a Zero-COVID strategy using nirmatrelvir/ritonavir, vaccination and NPIs in Wallis and Futuna (2022) (1)
- Reply (2016) (1)
- Infections à VIH nouvellement découvertes dans le nord et le nord-est de la France : données 2000 et 2001 (2003) (1)
- Rapid detection of glycopeptide-resistant enterococci: impact on decision-making and costs (2013) (1)
- Opérationnalisation de la randomisation d’un essai vaccinal en population générale africaine : exemple de l’essai PREVAC (« Partnership for Research on Ebola Vaccination ») (2017) (1)
- Mise en place d’un circuit ambulatoire de prise en charge des patients suspects d’infection COVID-19 (2020) (0)
- [When to initiate antiretroviral therapy and what to start with?]. (2006) (0)
- Reply (2017) (0)
- Correction to: Partnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countries (2021) (0)
- Modelling the potential effectiveness of hepatitis C screening and treatment strategies during pregnancy in Egypt and Ukraine. (2023) (0)
- O270 Methicillin-resistant Staphylococcus aureus clones producing toxic shock syndrome toxin 1: first case of intrafamily transmission (2007) (0)
- Immunogenicity of a BNT162b2 Vaccine Booster Against SARS-CoV-2 Delta and Omicron Variants in Older People (2022) (0)
- Cost-Effectiveness of Anti-Rabies Prophylaxis After Exposure to Unobservable Dogs in Eradication Context: The French Case (2013) (0)
- HIV therapeutic vaccine enhances non-exhausted CD4+ T cells in a randomised phase 2 trial (2019) (0)
- Reply to “Addressing opioid use disorder in modeling hepatitis C transmission among persons who inject drugs” (2017) (0)
- Interventions against HCV & HIV Infections among People who Inject Drugs (PWID) in Eastern Europe & Central Asia: A Modeling and Cost-Effectiveness Study (2016) (0)
- Assessment of HIV-postexposure prophylaxis prescription quality after a training programme and assistance in decisions provided by a computer-based decision program: a cross-over study (2021) (0)
- THU-391-Impact of early screening and treatment of hepatitis C virus and improvements in risk reduction on HCV transmission among HIV-infected men who have sex with men in France: A modeling approach (2019) (0)
- MOSAIC: a European cohort study of human Mpox - the challenges of clinical research in outbreaks. (2023) (0)
- Depressive symptoms after hepatitis C cure and socio-behavioral correlates in aging people living with HIV (ANRS CO13 HEPAVIH) (2022) (0)
- Cost-Effectiveness of QuantiFERON-TB Test versus Intradermoreaction in the Diagnosis of Latent Tuberculosis Infection Around a Case of Active Tuberculosis (2008) (0)
- Randomized Multicenter Trial ( ANRS 130 Immunological Response : Results of a Immunosuppression Does Not Improve HIV-1-Infected Patients with Severe through Addition of Enfuvirtide in Naive Intensification of Antiretroviral Therapy (2013) (0)
- Contributions and challenges of community pharmacists during the COVID-19 pandemic: a qualitative study (2022) (0)
- Un germe et sa prévention : Clostridium diffi cile (2013) (0)
- Erythematous maculopapular rash in monkeypox virus infection: A retrospective case series of 30 patients (2023) (0)
- [Orf nodules or "hangovers"]. (2005) (0)
- Reply to Drs. Waters and Ahmad (2011) (0)
- Characteristics of human immunodeficiency virus exposure and predictors of time until access to postexposure prophylaxis: a prospective observational study. (2021) (0)
- Reply to comment on 'pharmacokinetics of etravirine, raltegravir and darunavir/ritonavir in treatment experienced patients' (2011) (0)
- Impact of admission to high-risk isolation room on patients’ and healthcare workers’ perceptions: A qualitative cross-assessment Approach (2020) (0)
- P652 Incidence, reasons, and risk factors for hospital admissions in patients starting their clinical management in the era of combination antiretroviral therapy (2007) (0)
- What Is The Hospital Economic Burden Of Hiv In France? Results from an analysis of the national french medical information system database (2016) (0)
- Low to undetectable Omicron BQ.1.1 neutralization by patient’s sera a month after initiation of AZD7442 600mg (2023) (0)
- MRI Features Associated With the Detection of Microbial Pathogens by CT-Guided Biopsy in Septic Spondylodiscitis (2020) (0)
- [HIV and hepatitis C seroconversions in nurses]. (2002) (0)
- ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19 (2022) (0)
- Review and methodological analysis of trials currently testing treatment and prevention options for COVID-19 globally (2020) (0)
- Effects of Remdesivir in Hospitalized Patients with COVID-19: Systematic Review and Individual Patient Data Meta-Analysis of Randomized Clinical Trials (2022) (0)
- Recurrence of breast cancer after anaesthesia (2020) (0)
- Histological features associated with Human Monkeypox Virus Infection in 2022 outbreak in a non-endemic country. (2022) (0)
- 661 ULTRASONOGRAPHIC (US) SCREENING OF HEPATOCELLULAR CARCINOMA (HCC) IN COMPENSATED CIRRHOSIS DUE TO HEPATITIS C VIRUS (HCV) IMPROVES SURVIVAL: A MODELING APPROACH (2013) (0)
- Agreement of respiratory viruses' detection between nasopharyngeal swab and bronchoalveolar lavage in adults admitted for pneumonia: a retrospective study (2023) (0)
- Cost-Effectiveness and Budget Impact of Interferon-Free Direct-Acting Antiviral (DAA)-Based Regimens for Chronic Hepatitis C Treatment. The French Case (2016) (0)
- P0794 : Relationship between HCV genotype, liver co-morbidities and fibrosis in the French cohort ANRS CO22 HEPATHER (2015) (0)
- A call to action toward integrated testing and earlier care for viral hepatitis, HIV, STIs and TB (2020) (0)
- Modeling remdesivir antiviral efficacy in COVID-19 hospitalized patients of the randomized, controlled, open-label DisCoVeRy trial (2021) (0)
- [Evaluation of a quantitative HBV-DNA PCR assay in lamivudine treated hepatitis B-infected patients]. (2002) (0)
- Adaptation and Response of a Major Parisian Referral Hospital to the COVID-19 Surge: A Qualitative Study. (2023) (0)
- Can we talk about price with patients when choosing antiretroviral therapy? A survey with people living with HIV and prescribers in France (2021) (0)
- [Disseminated cytosteatonecrosis of pancreatic origin]. (1993) (0)
- [Tenofovir-induced Fanconi syndrome and recovery after treatment cessation: A case report with physiological considerations]. (2017) (0)
- Improving the evidence for indicator condition guided HIV testing in Europe: Results from the HIDES II Study #_#x2013; 2012 #_#x2013; 2015 (2019) (0)
- Reply to: "Therapeutic drug monitoring for sofosbuvir and daclatasvir in transplant recipients with chronic hepatitis C and advanced renal disease". (2016) (0)
- How should chronic hepatitis B virus infection be managed in HIV-hepatitis B virus-coinfected patients not eligible for concomitant antiretroviral therapy? (2008) (0)
- Impact of a treatment as prevention strategy on hepatitis C virus transmission and on morbidity in people who inject drugs (2015) (0)
- Monkeypox. Reply. (2023) (0)
- [Not Available]. (2016) (0)
- [Chronic pyelonephritis and xanthogranulomatous pyelonephritis]. (2011) (0)
- [From ANRS to ANRS | MIE (Maladies infectieuses émergentes) : How France is adapting its response to emerging diseases]. (2021) (0)
- P853 Efficacy and tolerance of linezolid-rifampicin combination prolonged oral therapy for bone and joint infections (2007) (0)
- [Availability of antiretroviral agents in the city: a 1-year assessment in the Lille metropolitan area]. (2001) (0)
- Cost‐effectiveness of hepatitis C virus test‐and‐treat and risk reduction strategies among men who have sex with men living with HIV in France (2022) (0)
- Accelerating clinical trial implementation in the context of the COVID-19 pandemic: author's response (2022) (0)
- Clinical and Social Psychological Profiles of Patients with Chronic Hepatitis C Treated with IFN-Free Regimens in France (2016) (0)
- [Immune reconstitution syndrome related to a Mycobacterium avium complex infection, revealed by a mono-adenitis]. (2011) (0)
- Effectiveness and cost-effectiveness of antiviral treatment initiation in hepatitis C related decompensated cirrhosis in France (2017) (0)
- Population pharmacokinetics of Rilpivirine in HIV-1-infected patients treated with the single-tablet regimen rilpivirine/tenofovir/emtricitabine (2018) (0)
- THU-406-Cost-effectiveness analysis of “treat all” guidelines for chronic hepatitis C in Brazil (2019) (0)
- A comparison of the incidence and cost of needlestick injuries in Germany, the United Kingdom, France, and the United States: A-964 (2006) (0)
- A-963 Performance of oxygen therapy masks when oxygen and nitrous oxide are coadministered (2009) (0)
- Bacterial infections in hospitalized HIV patients (1998) (0)
- Strengthened Ebola surveillance in France during a major outbreak in West Africa: March 2014–January 2016 (2017) (0)
- CYTOSTEATONECROSE DISSEMINEE D'ORIGINE PANCREATIQUE (1993) (0)
- Acute respiratory distress syndrome and severe acute respiratory syndrome: circulating interleukin 4 level could be a marker (2004) (0)
- [Varicella after Varivax® vaccine in a pregnant woman]. (2011) (0)
- Cannabis Use and Plasma Human Immunodeficiency Virus (HIV) RNA Levels in Patients Coinfected With HIV and Hepatitis C Virus Receiving Antiretroviral Therapy: Data From the ANRS CO13 HEPAVIH Cohort (2020) (0)
- [Pulmonary hydatid cysts: chemotherapy as a complement to surgical treatment]. (2004) (0)
- Controlling the Spread of Extended-Spectrum β-Lactamase-Producing Escherichia coli (ESBL-EC) in the Community: A Mathematical Model Simulating Household Circulation and the Impact of Interventions (2020) (0)
- Corrigendum to “Review of trials currently testing treatment and prevention of COVID-19” [Clin Microbiol Infect 26.8 (2020) 988–998] (2021) (0)
- Network Modeling of HIV-1 Transmission Networks in Houston, Texas, USA (0)
- 796 FACTORS ASSOCIATED WITH SUSTAINED VIROLOGICAL RESPONSE IN HCV/HIV PATIENTS RETREATED WITH PEG-INTERFERON-a2a-360 μg/wk AND RIBAVIRIN HIGH DOSE: RESULTS OF THE ANRS-HC-20 ETOC STUDY (2013) (0)
- Severe Strongyloidiasis in AIDS: Is Steroid Therapy Guilty Again? (2008) (0)
- HepCare Europe: a new user-friendly hepatitis C care service model. What have we learned? What are the remaining challenges? (2019) (0)
- [Multiple Aggregatibacter actinomycetemcomitans skin abscesses]. (2010) (0)
- ICD-10 codes of signs that may be related to Chikungunya virus infection. (2013) (0)
- Covid-19: from crisis management to sustainable solutions (2021) (0)
- Quantitative Methods Used to Evaluate Impact of Combination HIV Prevention Intervention: A Methodological Systematic Review (2023) (0)
- Comparison of impact and cost effectiveness of HPV vaccination and screening in the prevention of cervical cancer through a multiple cohorts Markov model in France (2007) (0)
- Development and Validation of an HIV/AIDS Empowerment Scale for Impact Intervention Evaluation. An Example from the MAKASI Intervention (2021) (0)
- ID-02 - Outbreak of Pneumocystis jirovecii pneumonia among heart transplant recipients : role of prophylaxis ? (2016) (0)
- Brief Report: Efficacy and Safety of Efavirenz, Raltegravir, and Dolutegravir in HIV-1/TB Coinfection. A Multicenter Retrospective Cohort Study in France (2022) (0)
- [Fighting infectious diseases: A never-ended renewed challenge]. (2022) (0)
- Comparative Effectiveness of Interventions to Improve the HIV Continuum of Care and HIV Preexposure Prophylaxis in Kenya: A Model-Based Analysis (2020) (0)
- SIRS, In a previous issue of Alimentary Pharmacology & Therapeutics, recommen- dations were published on the management of H1N1v infection in patients with (2011) (0)
- Transient viral exposure drives functionally-coordinated humoral immune responses in HIV-1 post-treatment controllers (2022) (0)
- SAT0389 Mri predictive factors for positive ct-guided biopsy in suspected septic spondylodiscitis (2018) (0)
- Implementation of a centralized pharmacovigilance system in academic pan‐European clinical trials: Experience from EU‐Response and conect4children consortia (2023) (0)
- Routine HIV screening in France: an estimation of clinical impact and cost-effectiveness. (2010) (0)
- Serum neutralization of SARS coronavirus 2 Omicron sublineages BA.1 and BA.2 and cellular immune responses 3 months after booster vaccination (2022) (0)
- Tipranavir in highly ARV-experienced patients: efficacy and tolerability results from the French prospective NADIS cohort (2008) (0)
- Innate immune deficiencies are associated with severity and poor prognosis in patients with COVID-19 (2022) (0)
- [MOSAIC: a European cohort study of human Mpox - the challenges of clinical research in outbreaks]. (2023) (0)
- Repurposed prophylaxis strategies for COVID-19: a systematic review (2020) (0)
- Therapeutic Drug Monitoring in HIV Treatment: A Literature Review (2006) (0)
- Determinant associated with seropositivity for CMV: multivariate analysis including all determinants with a p-value<0.20 in the univariate analysis. (2014) (0)
- Étude de la prévalence et des facteurs associés à l’attrition chez les patients atteints de tuberculose-maladie (2017) (0)
- [Not Available]. (2016) (0)
- Une éruption à dormir debout (2013) (0)
- Prise en charge multidisciplinaire de patientes ayant subi des mutilations sexuelles féminines en service de maladies infectieuses : un exemple de parcours en santé sexuelle (2019) (0)
- Bilan d’une expérimentation de suivi partagé ville–hôpital pour les personnes vivants avec le VIH (PVVIH) contrôlées (2021) (0)
- COL 09-01 - Facteurs socio-démographiques influant la propagation d’une épidémie : utilisation des données de contact (2013) (0)
- [Not Available]. (2016) (0)
- B-12 - Une éruption à dormir debout (2013) (0)
- Émergence de variants E484 K suite à une monothérapie bamlanivimab chez des patients COVID-19 à haut risque d’évolution vers une forme sévère (2021) (0)
- Léchage canin et infections systémiques à P. multocida (2000) (0)
- Caractéristiques sociodémographiques et modes d’exposition chez les patients hospitalisés pour COVID-19 avant et pendant la période de confinement (2020) (0)
- COL09-01 : Procréation chez les couples VIH séro-différents : TasP, PrEP ou AMP ? (ANRS 12008) (2014) (0)
- [Not Available]. (2016) (0)
- K-02 Caractéristiques cliniques, biologiques et thérapeutiques des patients de la cohorte NADIS suivis aux Antilles-Guyane et en France métropolitaine (2008) (0)
- Anti-intégrases et inhibiteurs du CCR5 : quelles places dans l'arsenal thérapeutique? (2008) (0)
- E-02 Morbi-mortalit prcoce des infections de prothse vasculaire (IPV) : propos de 62 cas (2008) (0)
- État de santé des personnes migrantes vues au pôle santé d’un centre de premier accueil en France (2018) (0)
- Prise en charge de l’infection par le virus de l’hépatite C chez les patients infectés par le VIH : évolution dans 3 cohortes consécutives entre 2004 et 2009 en France (2010) (0)
- COL5-01 Infections de prothèses vasculaires (IPV) : quelle antibiothérapie faut-il proposer en postopératoire ? En fonction du délai et de la localisation ? (2009) (0)
- Les facteurs de non-compliance chez le patient infecté par le VHC (2003) (0)
- Analyse coût/efficacité de la vaccination contre les infections HPV pour la prévention des cancers du col de l'utérus: apport d'un modèle de Markov à générations multiples (2007) (0)
- VIH-14 - Changement de traitement d’atazanavir (ATV) boosté + FTC/TDF vers une trithérapie à comprimé unique (STR) à base de TAF chez des patients adultes en succès virologique : résultats à 48 semaines (2016) (0)
- Faisabilité du dépistage généralisé du VIH, VHB et VHC par les médecins généralistes de Gironde et du Nord en 2012 (2013) (0)
- Prescription des bloqueurs du SRAA avant et après l’admission chez les patients hospitalisés pour COVID-19, et association avec la mortalité. Implications pour l’interprétation des études observationnelles sur le rôle des bloqueurs du SRAA durant l’infection à SARS-CoV-2 (2020) (0)
- [Not Available]. (2016) (0)
- Détection et génotypage « multisite » des Papillomavirus Beta au cours d’un cas d’épidermodysplasie verruciforme (EV) associée à l’infection VIH (2017) (0)
- COL 08-02 - Dolutegravir + abacavir/lamivudine une fois par jour est supérieure à efavirenz/ténofovir/emtricitabine chez des adultes infectés par le VIH-1 : résultats à 48 semaines de l’étude randomisée, en double aveugle SINGLE (2013) (0)
- Réactivation de tuberculose après traitement immunomodulateur pour une infection sévère à SARS-CoV-2 (2022) (0)
- Iconographies supplémentaires de l'article : Actualité de la rougeole (2015) (0)
- Répondre aux maladies infectieuses : un défi toujours renouvelé (2022) (0)
- J-05 Intérêt du suivi sérologique initial et post vaccinal de l’hépatite A chez les patients infectés par le VIH (2009) (0)
- G-04 Comparaison de l’efficacité et de la tolérance des associations rifampicine-linézolide (RL) et rifampicine-cotrimoxazole (RC) pour le traitement des infections ostéoarticulaires (IOA) (2008) (0)
- COL5-05 Y a-t-il une association entre la gravité des méningoencéphalites herpétiques (MEH) et la charge virale (CV) d’Herpes simplex Virus (HSV) dans le LCR ? (2008) (0)
- Syndrome de Fanconi lié au Tenofovir et récupération à l’arrêt du traitement : considérations physiologiques à propos d’un cas (2017) (0)
- K-06 Caractéristiques des patients de la cohorte NADIS sous antirétroviraux depuis plus de 10 ans (2008) (0)
- Virus émergents à localisation pulmonaire (2005) (0)
- Faut-il repenser le dépistage ? (2011) (0)
- Algorithme diagnostique des pneumonies aiguës communautaires : le « PACSCAN score » (2018) (0)
- VIH-19 - Comparaison randomisée, en double aveugle, de ténofovir alafénamide (TAF) vs ténofovir disoproxil fumarate (TDF), en association avec elvitégravir, cobicistat et emtricitabine (E/C/F) en initiation de traitement du VIH-1 : résultats à 96 semaines (2016) (0)
- J-10 - Utilisation des fluoroquinolones dans le traitement de la tuberculose : étude de pratique sur la métropole lilloise de 2004 à 2009 (2012) (0)
- Déterminants du dépistage récent du VIH chez les hommes ayant des rapports sexuels avec des hommes : Bordeaux, Lille, Marseille, Montpellier, Nice, Paris, France (2013) (0)
- Méningococcémie chronique : une présentation rare et moins buyante d’infection à méningocoque (2016) (0)
- Impact de la pandémie de COVID-19 sur les populations sans domicile fixe : résultats d’une cohorte fermée rétrospective (mars–mai 2020) (2021) (0)
- Une approche intégrative pour la caractérisation initiale de l’épidémie due au virus MERS-CoV (2014) (0)
- [Not Available]. (2016) (0)
- MYCOBACT-15 - Pharmacocinétique plasmatique de la bédaquiline lors du traitement des tuberculoses MDR/XDR (2016) (0)
- Les résultats de sérologies de syphilis rendus par les laboratoires de ville sont-ils fiables ? (2017) (0)
- Quelle prophylaxie contre la rage après une exposition en France (2013) (0)
- Prophylaxie pré exposition au VIH (PrEP) dans une population transgenre (2018) (0)
- Prophylaxie pré-exposition au VIH (PrEP) dans la population transgenre : suivi à 3 ans dans un CeGIDD hospitalier (2019) (0)
- Influence de la pandémie de la COVID-19 sur le dépistage de l’infection par le VIH (2021) (0)
- P-11: Intérêt de la tomographie d’émission de positons en maladies infectieuses (2014) (0)
- Mieux VIHeillir : étude descriptive d’une population gériatrique VIH (2018) (0)
- Parcours migratoire des demandeurs d’asile vers la France (2019) (0)
- Transmission d’Escherichia coli résistant aux β-lactamines (E. coli BLSE) dans la communauté : modélisation et évaluation de l’impact des interventions (2019) (0)
- Efficacité et coût-efficacité de la vaccination contre le rotavirus en france (2007) (0)
- COL6-04 Tolérance de linézolide-rifampicine (LZD-RIF) dans les infections ostéo-articulaires (IOA) (2008) (0)
- L’hospitalisation en chambre dédiée au risque épidémique et biologique : quels impacts sur les patients et les soignants ? Une approche qualitative (2020) (0)
- Défis pour la prévention du VIH chez les personnes transgenres hommes vers femmes, dans un centre hospitalier français, en 2017 (2019) (0)
- [23es Rencontres du Groupe d'expertise et d'information sur la grippe (GEIG, www.grippe-geig.com)]. (2011) (0)
- I-07 Quinolones versus macrolides dans le traitement de la légionellose : revue systématique et méta-analyse de la littérature (2014) (0)
- Syndrome de restauration immunitaire chez les patients infectés par le virus de l’immunodéficience humaine et traités par antirétroviraux (2013) (0)
- A-22: La généralisation des TROD VIH ne risque-t-elle pas d’augmenter le sous-diagnostic des hépatites virales ? (2014) (0)
- Caractéristiques microbiologiques et cliniques des patients hospitalisés pour suspicion d’infection à Middle East Respiratory Syndrome coronavirus (MERS-CoV) au cours de la période 2013–2016 (2017) (0)
- PADS 1-05 - Modélisation des coûts et bénéfices des stratégies de contrôle de la transmission des entérobactéries productrices de β-lactamases à spectre étendu (EBLSE) dans un service de réanimation (2016) (0)
- Les antirétroviraux en monoprise quotidienne, une possibilité d'observance dirigée de type « Dot » de la tuberculose (2003) (0)
- Enterobacteriaceae bacteremia: Risk factors for ESBLPE Bactériémie à entérobactérie : facteurs de risque de EBLSE (2013) (0)
- A-07 : Conséquences individuelles et collectives des ruptures de suivi chez les patients porteurs du VIH (2014) (0)
- Caractéristiques à l’inclusion des patients présentant une tuberculose bacillifère et suivis dans l’étude Fast-TB (2018) (0)
- Traitement immédiat ou différé avec « prévir » chez les patients naïfs infectés par le VHC de génotype 1 (VHC-G1) en l’absence de fibrose sévère ? Une analyse coût–efficacité (ANRS no 121888) (2014) (0)
- L-01 Polymorphismes de la protéase du VIH-1 : impact sur l’efficacité d’un premier traitement antirétroviral comportant le lopinavir (2008) (0)
- Abcès cutanés multiples à Aggregatibacter actinomycetemcomitans (2010) (0)
- Coût-efficacité et VHC : mise au point (2014) (0)
- Le coût de la prise en charge du Syndrome Respiratoire Aigu Sévère (SRAS) au Centre Hospitalier de Tourcoing (2005) (0)
- TripTB : Evaluation des difficultés médico-psycho-sociales dans la prise en charge des patients atteints de tuberculose MDR et XDR dans un centre de référence (2019) (0)
- Modélisation et aide à la décision d'intégration de nouveau vaccin dans le calendrier: exemples récents (2008) (0)
- Complications à long terme des injections massives de silicones non médicaux : étude clinique et cytologique chez 77 transgenres ☆ (2016) (0)
- La ceftriaxone est non-inférieure à la pénicilline G dans le traitement de la neurosyphilis (2020) (0)
- La supervision, un élément central pour la sécurisation de la prise en charge des patients infectés par le SARS-CoV-2 (2020) (0)
- O-03: Prise en charge des infections sternales après chirurgie cardiaque (2014) (0)
- Les étrangers précaires exclus de l’Assurance Maladie en service de maladies infectieuses (EPSAMI) : conséquences médicales et financières (2020) (0)
- Vaccins COVID-19 : une course contre la montre (2021) (0)
- U-07 Complications graves de l’immunothérapie intravésicale par Bacille de Calmette et Guérin : caractéristiques cliniques et thérapeutiques - à propos de 11 cas (2008) (0)
- Caractéristiques des PVVIH d’origine maghrébine (2017) (0)
- Programme hospitalier de bon usage des antibiotiques : le point de vue des prescripteurs, une enquête nationale (2018) (0)
- Caractéristiques cliniques et paracliniques de 4 patients confirmés à COVID-19 (2020) (0)
- Traitement immédiat ou différé chez les patients infectés par le VHC de génotype 4 dans un pays à ressources limitées : une analyse coût–efficacité en Égypte (ANRS 12215) (2014) (0)
- Étude pilote sur la corrélation entre le score d'aération pulmonaire par échographie et la performance au test de marche de 6 minutes chez les patients hospitalisés pour COVID-19 (2022) (0)
- Varicelle chez une femme enceinte malgré une vaccination par Varivax (2011) (0)
- Évaluation prospective de l’initiation d’un traitement antirétroviral par l’association TAF/FTC/BIC au stade de la primo-infection VIH (2020) (0)
- [Not Available]. (2016) (0)
- K-04 Caractéristiques des femmes infectées par le VIH1 prises en charge en 2007 dans la cohorte NADIS (2008) (0)
- Q-03 Infection cutanée à Staphylococcus aureus (S. aureus) producteur de la toxine de Panton-Valentine (PVL) dans la région Nord-Pas-de-Calais (NPC) ; 2004 à 2008 (2009) (0)
- N-03 - Efficacité, coût et coût-efficacité de l’utilisation des Tests de Diagnostic Rapide (TDR) dans la prévention contre le tétanos aux urgences en France (2012) (0)
- Efficacité et tolérance à long terme du STR à base de TAF elvitegravir/cobicistat/emtricitabine/ténofovir alafénamide (E/C/F/TAF) chez des adultes naïfs de traitement (2017) (0)
- Dépistage multisites de Neisseria gonorroheae et Chlamydia trachomatis chez les hommes ayant des rapports sexuels avec des hommes (HSH) et les patients transgenres hommes/femmes (TG). 2 ans d’expérience en CeGIDD hospitalier (2018) (0)
- Amputations autour du genou : rôle pronostique des cultures par biopsie osseuse (2013) (0)
- Contrôle sous-optimal de l’infection VIH chez les patientes transgenres, homme vers femme, en 2017, dans un centre hospitalier universitaire (2018) (0)
- VIH-15 - Ténofovir alafénamide en remplacement de ténofovir disoproxil fumarate chez des adultes en succès virologique (2016) (0)
- K-05: Élaboration d’un score prédictif de tuberculose (TB) pulmonaire chez des patients suspects de tuberculose : une étude cas-témoins (2014) (0)
- AT02-04 Isolement de la femme séropositive : une réponse possible l’éducation collective (2009) (0)
- EMERG-04 - L’après Ebola : que reste-t-il des compétences des soignants d’un établissement sanitaire de référence (ESR) ? (2016) (0)
- Description des systèmes d’aide à la prescription antibiotique disponibles en langue française (2021) (0)
- Séroconversions par le VIH et le VHC chez les soignants (2002) (0)
- MYCOBACT-16 - Tolérance et efficacité d’un traitement prolongé avec bédaquiline dans la tuberculose multi résistante (2016) (0)
- Cohorte tuberculose (CO1TB) dans le Nord de Paris : état des lieux (2020) (0)
- COVID-19 : les thérapeutiques (2022) (0)
- Coût-efficacité de la vaccination contre les hépatites (2008) (0)
- Les inhibiteurs de CCR 5 þ : une nouvelle classe d ’ antirétroviraux CCR 5 antagonists : a new class of antiretrovirals X . (2008) (0)
- Indications et tolérance des fluoroquinolones dans le traitement de la tuberculose : étude des pratiques dans le Nord de la France et dans le Nord de Paris de 2004 à 2011 (2013) (0)
- G-03 Comparaison des taux sériques de vancomycine (V) et de teicoplanine (T) chez des patients traités dans le cadre d’infection sur matériel orthopédique (IMO) (2008) (0)
- [Not Available]. (2016) (0)
- H-35 Facteurs associés au coût d’un premier traitement antirétroviral (ART) chez les patients vivant avec le VIH (2009) (0)
- Impact des interventions impactant la cascade de soin de l’infection VIH et la prophylaxie pré-exposition dans le sud-ouest kenyan (2019) (0)
- Description des cas possibles de COVID-19 dans un établissement de santé de référence (2020) (0)
- [Not Available]. (2016) (0)
- Tuberculose et issues de traitement: données de la cohorte prospective, multicentrique CO1TB (2021) (0)
- Que pensent les médecins généralistes d’un suivi partagé ville–hôpital des personnes vivant avec le VIH ? Une étude qualitative (2021) (0)
- Syndrome inflammatoire de restauration immunitaire associée à une infection à Mycobacterium avium complex revélée par une mono-adénite (2011) (0)
- Prise en charge des patients atteints du syndrome respiratoire aigu sévère : CH de Tourcoing (2004) (0)
- H-21 Résultats préliminaires du dosage de la vitamine D chez des patients vivants avec le VIH, suivis dans le Nord de la France (2009) (0)
- Évolution à 2 ans de 415 patients VIH naïfs dépistés pour la tuberculose latente par IGRA : suivi à long terme de l’étude IGRAVIH. NCT00805272 (2015) (0)
- TROP-03 - Arboviroses et voyageurs : l’expérience d’une consultation de pathologies tropicales (2016) (0)
- Once‐daily darunavir/ritonavir 400/100 mg in triple therapy: efficacy and penetration in seminal compartment in ANRS‐165 DARULIGHT study (2018) (0)
This paper list is powered by the following services:
Other Resources About Yazdan Yazdanpanah
What Schools Are Affiliated With Yazdan Yazdanpanah?
Yazdan Yazdanpanah is affiliated with the following schools:
